2014 Annual Meeting | Poster Session 6

Date Thursday 05/01/14

Time 07:30 AM - 11:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-ophthalmology/Neuro-otology

CME Available No CME available

Event Timeline
07:30 AM - 11:00 AM	Abstract	001 - Analyses Of Neural Autoantibodies By a Clinical Laboratory For The Evaluation Of Paraneoplastic And Non-Paraneoplastic Neuronal Disorders Valerie Brachet, PhD
07:30 AM - 11:00 AM	Abstract	002 - Cross-cultural comparison of stigma toward mental and neurological disorders Laila Gharzai
07:30 AM - 11:00 AM	Abstract	003 - Efficacy of Dalfampridine in Hereditary Spastic Paraplegia: a prospective open study Nicolas Collongues, MD
07:30 AM - 11:00 AM	Abstract	004 - Multidisciplinary Management of Cerebral Edema Associated with Fulminant Hepatic Encephalopathy in a Neurosciences Intensive Care Unit Panayiotis N. Varelas, MD, PhD, FAAN
07:30 AM - 11:00 AM	Abstract	006 - Discharge Delays on an Inpatient Neurology Service Ayush Batra, MD
07:30 AM - 11:00 AM	Abstract	007 - Taking Neurology to the Underserved - A Pilot Initiative in an Urban Homebound Program Ritesh Ramdhani, MD
07:30 AM - 11:00 AM	Abstract	008 - Chronic inflammatory demyelinating polyneuropathy (CIDP) sera alter regulators of Schwann cell differentiation Abhijeet R. Joshi
07:30 AM - 11:00 AM	Abstract	009 - Methotrexate Induced Cerebellar Leukoencephalopathy Christopher M. Goshgarian, MD
07:30 AM - 11:00 AM	Abstract	010 - Subclinical primary Sjögren's Syndrome and associated peripheral neuropathy: optimizing diagnostic approach. Etienne Laverse, MBBS, BSc, MRCP
07:30 AM - 11:00 AM	Abstract	011 - Recurrent Stroke-like Events Preceding the X-linked Charcot-Marie-Tooth Disease Diagnosis Tara Kimbason, MD, MPH
07:30 AM - 11:00 AM	Abstract	012 - Abnormal white matter connectivity in children with autism or sensory processing disorder: overlap and divergence. Elysa Marco, MD
07:30 AM - 11:00 AM	Abstract	013 - An Abbreviated Exposure to Chronic Hypoxia is Sufficient to Induce CNS Hypomyelination and Impair Motor Development in Neonatal Mice Jens Watzlawik
07:30 AM - 11:00 AM	Abstract	014 - Infraslow Electroencephalography Changes in Infantile Spasms Ken Myers, MD, PhD
07:30 AM - 11:00 AM	Abstract	015 - Anti NMDA Receptor Encephalitis (ANMDARE): Outcome in a Cohort of 13 Children Jay E. Selman, MD
07:30 AM - 11:00 AM	Abstract	016 - Novel Mechanism for Monitoring Cerebral Hemodynamics in Pediatric ECMO David R. Busch, PhD
07:30 AM - 11:00 AM	Abstract	017 - Stiff Person Syndrome in Childhood: SPS-C Recognition and Review Bennett L. Lavenstein, MD, FAAN
07:30 AM - 11:00 AM	Abstract	018 - A Rare Case of Microcephaly-Capillary Malformation Syndrome Diagnosed via Whole Exome Sequencing Nassim Zecavati, MD, FAAN
07:30 AM - 11:00 AM	Abstract	019 - Does Duration of Steroid Treatment Matter in Pdiatric Optic Neuritis? Himali R. Jayakody, MD
07:30 AM - 11:00 AM	Abstract	020 - Functional Neurological Disorder In The Pediatric Emergency Room: Characteristics, Outcome And Diagnostic Accuracy Claudio M. DeGusmao, MD
07:30 AM - 11:00 AM	Abstract	021 - Postural Orthostatic Tachycardia Syndrome (POTS) and its associated symptoms Anindita Deb, MD, FAAN
07:30 AM - 11:00 AM	Abstract	022 - Neurological Sequelae of Varicella Zoster Virus Infection ( VZV): Case Series of Varied Presentations Shamaehah Javed, MD
07:30 AM - 11:00 AM	Abstract	023 - Hashimoto's Encephalopathy Complicated by Cerebellar Ataxia: A Case Report Michael Hossack, MD
07:30 AM - 11:00 AM	Abstract	024 - Unusual Presentation of Acute Carbon Monoxide Poisoning Shivnaveen Bains, MD
07:30 AM - 11:00 AM	Abstract	025 - Dabigatran -The future of cortical venous thrombosis therapy -a case series study Thomas Mathew, MD
07:30 AM - 11:00 AM	Abstract	026 - Intrathecal Baclofen Toxicity Mimicking Nonconvulsive Status Epilepticus Glynnis Zieman, MD, MPH, FAAN
07:30 AM - 11:00 AM	Abstract	027 - Case Report: Uncommon Presentation of Neurosarcoidosis Ikjae Lee, MD
07:30 AM - 11:00 AM	Abstract	028 - Central Pontine and Extrapontine Myelinolysis: Risk Factors and Clinical Expression in Liver Transplanted Patients
07:30 AM - 11:00 AM	Abstract	029 - Unusual Case of Delayed Postpartum Preeclampsia Associated with Reversible Splenial Lesion Syndrome Pedro S. Oliveira, MD
07:30 AM - 11:00 AM	Abstract	030 - Hypercholesterolemia and Neurological Diseases Related Mortality in the NEDICES Cohort
07:30 AM - 11:00 AM	Abstract	031 - Atypical Presentation of Posterior Reversible Encephalopathy Syndrome Annapoorna Bhat, MD
07:30 AM - 11:00 AM	Abstract	032 - Neurological Disorders In Rosai-Dorfman Disease
07:30 AM - 11:00 AM	Abstract	034 - The Need for Repeat Diagnostic Testing for the Identification of Ovarian Pathology in a Patient with anti-NMDA Receptor Limbic Encephalitis Mona Bahouth, MD
07:30 AM - 11:00 AM	Abstract	035 - Quality Improvement: Maintaining an Accurate Medication List by Standardizing the Outpatient Medication Reconciliation Method Christina M. Nguyen, MD
07:30 AM - 11:00 AM	Abstract	036 - Guillain-Barre in a Small Illinois Community: An Epidemiology Perspective
07:30 AM - 11:00 AM	Abstract	037 - The Epidemiology of Neuromyelitis Optica at a City Hospital in the Bronx, New York Sylvia A. Mohen, MD
07:30 AM - 11:00 AM	Abstract	038 - Symptomatic Vitamin D deficiency in Dubai
07:30 AM - 11:00 AM	Abstract	039 - Hyperkalemic Periodic Paralysis Masquerading as Sleep Paralysis Yelena G. Pyatkevich, MD
07:30 AM - 11:00 AM	Abstract	040 - POEMS syndrome associated with autoimmune limbic encephalitis, an unusual occurrence Niraj A. Arora, MD
07:30 AM - 11:00 AM	Abstract	041 - Neuroscience Education in the Medical College: The Qatar Experience Leopold J. Streletz, MD, FAAN
07:30 AM - 11:00 AM	Abstract	042 - Posterior Reversible Encephalopathy Syndrome and Guillain - Barre Syndrome in a Pregnant Lady: A Case Report From A Tertiary Teaching Hospital Of South India Dhairyawan Pokalkar, MD, FAAN
07:30 AM - 11:00 AM	Abstract	043 - Spinal Cord damage in Machado-Joseph disease
07:30 AM - 11:00 AM	Abstract	044 - The Evaluation of Swallowing in patients with Spinocerebellar Ataxia and Oropharyngeal Dysphagia: a comparison study of Videofluoroscopic and Sonar Doppler
07:30 AM - 11:00 AM	Abstract	045 - Polysomnographic findings in Machado-Joseph disease: evaluation of 47 patients Jose Luiz Pedroso, MD
07:30 AM - 11:00 AM	Abstract	046 - De Novo Deletion of AFG3L2 Causing Spinocerebellar Ataxia Type 28 in the Context of Multiple Genomic Anomalies Ken Myers, MD, PhD
07:30 AM - 11:00 AM	Abstract	047 - Coenzyme Q10, Statin, and Spinocerebellar Ataxias Sheng-Han Kuo, MD
07:30 AM - 11:00 AM	Abstract	048 - Audiological Evaluation in Spinocerebelar Ataxia Helio Afonso G. Teive, MD
07:30 AM - 11:00 AM	Abstract	049 - Wide Spectrum of Clinical Presentation of Spinocerebellar Ataxia Type 2 Shilpa Kolli
07:30 AM - 11:00 AM	Abstract	050 - Widespread Cerebral Cortical Damage in Machado-Joseph Disease
07:30 AM - 11:00 AM	Abstract	051 - Dystonia In Machado-Joseph Disease: Clinical Features And Levodopa Response
07:30 AM - 11:00 AM	Abstract	052 - Treatment of Spinocerebellar Ataxia with Intravenous Immune Globulin (IVIG) Theresa A. Zesiewicz, MD
07:30 AM - 11:00 AM	Abstract	053 - Paroxysmal Dysarthria and Ataxia after Treatment of Brainstem Encephalitis James P. Klaas, MD, FAAN
07:30 AM - 11:00 AM	Abstract	054 - Sporadic Cerebellar GAD-Ataxia: A Retrospective Analysis Pezhman Roohani, MD
07:30 AM - 11:00 AM	Abstract	055 - Elevated Thyroid Antibody Associated Sporadic Cerebellar Ataxia: A Retrospective Analysis Pezhman Roohani, MD
07:30 AM - 11:00 AM	Abstract	056 - Autoimmune Cerebellar Degeneration with Voltage Gated Calcium Channel Antibodies: A Case Report and Study of Antibody Reactivity Marilyn J. McKasson, MD
07:30 AM - 11:00 AM	Abstract	057 - Cerebellar ataxia with CoQ10 deficiency due to a novel mutation in ADCK3 Emanuele Barca, MD, PhD
07:30 AM - 11:00 AM	Abstract	058 - A novel spinocerebellar ataxia with hematologic cytopenias: linkage analysis and exome sequencing identifies a candidate gene Dong-Hui Chen, MD, PhD
07:30 AM - 11:00 AM	Abstract	059 - iPatax: A new method for quantitative assessment for motor coordination of ataxia Masayoshi Tada, MD, PhD
07:30 AM - 11:00 AM	Abstract	061 - Spinocerebellar Ataxias with Hypogonadism: Unraveling a Novel Group of Inherited Neurometabolic Disorders Charles M. Lourenco, MD, PhD
07:30 AM - 11:00 AM	Abstract	062 - The use of Adjustments to facilitate the written in patients diagnosed with Spinocerebellar Ataxia
07:30 AM - 11:00 AM	Abstract	063 - Cognitive Associations of White Matter Hyperintensities in Non-Demented Parkinson's Disease Patients: A Voxel-Wise Lesion Probability Study Elijah Mak
07:30 AM - 11:00 AM	Abstract	064 - A Longitudinal [11C](±)dihydrotetrabenazine PET Study of Gender Difference in the Progression of Dopaminergic Dysfunction in the Parkinsonian Caudate Nandhagopal Ramachandiran, MBBS, DM, FRCP, FAAN
07:30 AM - 11:00 AM	Abstract	066 - Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease Gaetan Garraux, MD
07:30 AM - 11:00 AM	Abstract	067 - Subcortical atrophy is associated with cognitive impairment in mild Parkinson's disease: a combined volumetric and vertex-based shape analysis study
07:30 AM - 11:00 AM	Abstract	068 - Cerebellar Atrophy in Patients with Parkinson's Disease Using the SUIT tool for Voxel-Based Morphometry
07:30 AM - 11:00 AM	Abstract	069 - Quantitative MRI Biomarker Study in Parkinson's Disease: High-field 1H-MR Spectroscopic and Multi-Modal MRI Longitudinal Study of the Substantia Nigra Navid Seraji-Bozorgzad, MD
07:30 AM - 11:00 AM	Abstract	070 - Accuracy and diagnosis cutoff points of 123I-metaiodobenzylguanidine myocardial scintigraphy for Lewy body disease diagnoses in parkinsonian syndromes: a study of 62 consecutive patients in an expert center. Guillaume Lamotte, MD
07:30 AM - 11:00 AM	Abstract	071 - Multi-Modal High-Field MRI Longitudinal Study of the Deep Gray Matter, Frontal Lobe, and Corpus Callosum in Parkinson's Disease.
07:30 AM - 11:00 AM	Abstract	073 - Stimulating Frontostriatal Circuitry to Treat Motor and Non-Motor Symptoms of Parkinson's Disease Nolan Williams, MD
07:30 AM - 11:00 AM	Abstract	074 - Tinnitus after Deep Brain Stimulation Surgery, a Case Series Umer Akbar, MD
07:30 AM - 11:00 AM	Abstract	075 - Clinical Manifestations of Tolerance to Deep Brain Stimulation Deepal P. Shah-Zamora, MD
07:30 AM - 11:00 AM	Abstract	076 - Use of Interleaving in Deep Brain Stimulator Programming in Patients with Movement Disorders Joohi Jimenez Shahed, MD
07:30 AM - 11:00 AM	Abstract	077 - Clinical significance of abnormal electrode impedance readings in deep brain stimulation for treatment of movement disorders Olga Waln, MD
07:30 AM - 11:00 AM	Abstract	078 - A Case of Dystonic Head Tremor treated with Bilateral Globus Pallidus pars Interna Deep Brain Stimulation Joanna E. O'Leary, MD
07:30 AM - 11:00 AM	Abstract	079 - Parkinson's disease is associated with enhanced pain-related disability and the selective loss of gray matter in subcortical regions of the brain related to pain processing Andrew H. Ahn, MD, PhD
07:30 AM - 11:00 AM	Abstract	080 - Effect of laterality in Parkinson`s disease: a Voxel-based Morphometry Study Maria Cristina Arci Santos
07:30 AM - 11:00 AM	Abstract	081 - [18F]FDG PET, [18F]FP-CIT PET and MR Morphometry in Lewy body Dementia: Comparison with Alzheimer disease Hyunjin Kim, MD
07:30 AM - 11:00 AM	Abstract	083 - High Resolution Ultrasound in Combat-Related Peripheral Nerve Injuries: A Case Series Jonathan K. Smith, MD, FAAN
07:30 AM - 11:00 AM	Abstract	084 - Accuracy of Ultrasound for Diagnosis of Carpal Tunnel Syndrome in Patients with Bifid Median Nerve Jonathan M. Beary, DO, FAAN
07:30 AM - 11:00 AM	Abstract	085 - Distinctive Patterns of Sonographic Nerve Enlargement in Charcot-Marie-Tooth type 1A and Hereditary Neuropathy with Pressure Palsies. Stephan Goedee, MD
07:30 AM - 11:00 AM	Abstract	086 - Peripheral Nerve Ultrasound in Small Fiber Neuropathy Hamid Ebadi, MD
07:30 AM - 11:00 AM	Abstract	087 - Neuromuscular Ultrasound Findings in Eosinophilic Fasciitis Sarah Stone, MD
07:30 AM - 11:00 AM	Abstract	088 - The Value of Including Sweat Gland Nerve Fiber Density (SGNFD) Analysis in the Neuropathy Work-up Amiram Katz, MD
07:30 AM - 11:00 AM	Abstract	089 - 99mTc-DPD Cardiac Scintigraphy in Familiar Amyloidosis
07:30 AM - 11:00 AM	Abstract	090 - Blood pressure dipping during the deep breathing maneuver (BPDB) while supine may be a marker of severe sympathetic denervation Alexandru C. Barboi, MD
07:30 AM - 11:00 AM	Abstract	091 - Increased Frequency of Rhabdomyolysis in Familial Dysautonomia
07:30 AM - 11:00 AM	Abstract	092 - Subacute Onset of Severe Cidp Weakness Associated With Tumor-Like Nerve Root Involvement: A Case Report Sharon Stoll, DO
07:30 AM - 11:00 AM	Abstract	093 - Peripheral Neuropathy (PN) in Individuals with Neurofibromatosis Type 1 (NF1) and Plexiform Neurofibromas (PNF) Tanya J. Lehky, MD
07:30 AM - 11:00 AM	Abstract	094 - Evaluation of Central and Peripheral Neuropathy in Type 2 Diabetes: A Case-Control Study Prasanna Venkatesan Eswaradass, MD
07:30 AM - 11:00 AM	Abstract	095 - Idiopathic Peripheral Neuropathy and Subsequent Development of Diabetes Mellitus Ritika Mahajan, MD
07:30 AM - 11:00 AM	Abstract	096 - Opioid Usage in Peripheral Neuropathy: A Population-Based Study E. M. Hoffman, DO, PhD
07:30 AM - 11:00 AM	Abstract	097 - Reference Attributes of Nerve Conduction and Ethnicity: Comparison in Northern Plain Indians, Mexican Americans and Caucasians Rajat Lahoria, MD
07:30 AM - 11:00 AM	Abstract	098 - A Population-Based Epidemiologic Study of Adult Neuromuscular Disease in the Republic of Ireland Stela Lefter, MD
07:30 AM - 11:00 AM	Abstract	099 - Trends in Outcome and Cost of Hospitalization of Elderly Myasthenia Gravis Patients Treated with Plasmapheresis from 1992 to 2009 Mohammad H. El-Ghanem, MD
07:30 AM - 11:00 AM	Abstract	100 - Emerging Epidemiological Trends of Autoimmune Myasthenia Gravis in Connecticut Matthew Imperioli, MD
07:30 AM - 11:00 AM	Abstract	101 - “Fainting in teenagers is not always Faking” Sreenivas Avula, MD
07:30 AM - 11:00 AM	Abstract	102 - CNS Toxoplasmosis: A serious complication of immunotherapy in the neuromuscular patient Danilo Bernardo, MD
07:30 AM - 11:00 AM	Abstract	103 - Fingolimod (FTY720) Oral For The Treatment Of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Study Design Of The Phase 3 FORCIDP Trial Hans-Peter Hartung, MD, FAAN
07:30 AM - 11:00 AM	Abstract	104 - Characteristics of Muscle Cramps in Patients with Polyneuropathy Hans D. Katzberg, MD, FAAN
07:30 AM - 11:00 AM	Abstract	105 - Electrodiagnostic Profile of Demyelination in Diabetic Neuropathy: A novel approach Zubeda B. Sheikh, MD
07:30 AM - 11:00 AM	Abstract	106 - West Nile Virus Encephalomyelityis Simulating Brain Death Channaiah Srikanth Mysore
07:30 AM - 11:00 AM	Abstract	107 - Zoster Associated Limb Paresis (ZALP) is Associated with Prolonged Weakness and Pain: A Natural History Study Alex Nelson, MD
07:30 AM - 11:00 AM	Abstract	108 - Branching Enzyme Deficiency: Expanding The Clinical Spectrum
07:30 AM - 11:00 AM	Abstract	109 - Oxidative Metabolism During Forearm Exercise in McArdle disease Ronald G. Haller, MD
07:30 AM - 11:00 AM	Abstract	110 - The Pattern of Pain in Carpal Tunnel Syndrome Follows a Bell-shaped Curve Benn E. Smith, MD, FAAN
07:30 AM - 11:00 AM	Abstract	111 - When expected turns unexpected: A case of subacute progressive weakness and paresthesias of the distal lower extremities following a brief diarrheal episode. Divpreet Kaur, MD
07:30 AM - 11:00 AM	Abstract	112 - Clinical Impact of Brain Tissue Damage quantified by fully automated analysis of MR Images in patients with Multiple Sclerosis Alaleh Raji, MD
07:30 AM - 11:00 AM	Abstract	113 - Sub-optimal Response to Therapy in Disease-free MS Patients: A Paradox? Fernando F. Figueira, MD
07:30 AM - 11:00 AM	Abstract	114 - Longitudinal effects of interferon-beta-1a treatment on cortical thickness in relapsing-remitting multiple sclerosis patients Anat Achiron, MD, PhD, FAAN
07:30 AM - 11:00 AM	Abstract	115 - Associations Between Changes in Ferritin Levels and Susceptibility-Weighted Imaging Filtered Phase in Patients with Relapsing-Remitting Multiple Sclerosis over Six Months Therapy with Interferon Beta-1a Michael G. Dwyer III, MD, PhD
07:30 AM - 11:00 AM	Abstract	116 - Evolution of Corpus Callosum Index in Patients with Relapsing Remiting Multiple Sclerosis Treated with Natalizumab Eva Costa Arpin, MD
07:30 AM - 11:00 AM	Abstract	117 - Corpus Callosum Volume Change in the First Year is the Strongest Predictor of 9-year Clinical Disability in Multiple Sclerosis Dana Horakova
07:30 AM - 11:00 AM	Abstract	118 - A new composite scale of MRI-defined disease severity in multiple sclerosis Mohit Neema, MD
07:30 AM - 11:00 AM	Abstract	119 - Fully automated Detection and Quantification of T1 hypointense lesions in Multiple Sclerosis Alaleh Raji, MD
07:30 AM - 11:00 AM	Abstract	120 - Cerebellar and Brain Gray-Matter Damage Predicts Fatigue in Multiple Sclerosis Alfredo Damasceno, MD
07:30 AM - 11:00 AM	Abstract	121 - Abnormal White Matter fraction predicts cognitive dysfunction in Multiple Sclerosis patients Manuela De Stefano
07:30 AM - 11:00 AM	Abstract	122 - Diffusional Kurtosis MRI Correlates Of Cognitive Functions In Primary-Progressive MS Maria Petracca, PhD
07:30 AM - 11:00 AM	Abstract	123 - Functional Correlates of Impaired Working Memory in MS Patients: A Multicentre Study Alvino Bisecco
07:30 AM - 11:00 AM	Abstract	124 - Cognitive Reserve in Multiple Sclerosis Modulates Hippocampal Functional Connectivity and Protects from Memory Deficits Maria A. Rocca
07:30 AM - 11:00 AM	Abstract	125 - Iron In The Deep Gray Matter: Association With Cognitive Impairment In Multiple Sclerosis Claire Modica
07:30 AM - 11:00 AM	Abstract	126 - Brain White Matter Tract Microstructural Alterations in Multiple Sclerosis Patients with Depression and Fatigue: A Diffusion Tensor MRI Study Gianna Carla Riccitelli
07:30 AM - 11:00 AM	Abstract	127 - Contribution of Global and Regional Damage of the Gray and White Matter to Fatigue in MS
07:30 AM - 11:00 AM	Abstract	128 - Network efficiency as a final common pathway for cognitive deficits in multiple sclerosis: a single network graph theory study Matteo Pardini, MD, PhD
07:30 AM - 11:00 AM	Abstract	129 - Microstructural Damage to NAWM and GM but Not to Cortical Lesions Contributes to Cognitive Impairment in Multiple Sclerosis: A Diffusion Tensor MRI Study
07:30 AM - 11:00 AM	Abstract	130 - Patterns of Regional Gray Matter and White Matter Atrophy in “Cortical Multiple Sclerosis”
07:30 AM - 11:00 AM	Abstract	131 - The rate of new GM lesion development is similar in all MS disease subtypes Rasha Abdel-Fahim
07:30 AM - 11:00 AM	Abstract	132 - Global and Regional Brain Concentration of Intra- and Extra-cellular Sodium in MS: A 7 Tesla MRI Study
07:30 AM - 11:00 AM	Abstract	133 - Accrual and evolution of cortical gray matter lesions in people with relapse-onset multiple sclerosis Varun Sethi, MD, PhD
07:30 AM - 11:00 AM	Abstract	134 - MRI-Based Detection and Characterization of Leptomeningeal Contrast Enhancement in Multiple Sclerosis Luisa Vuolo
07:30 AM - 11:00 AM	Abstract	135 - The Use of BigBrain in MS: An Ultrahigh-resolution 3D Template for Grey Matter MRI Segmentation
07:30 AM - 11:00 AM	Abstract	136 - A Robust and Fast Algorithm for Quantifying Spinal Cord Cross-sectional Area in Myelitis Govind Bhagavatheeshwaran
07:30 AM - 11:00 AM	Abstract	137 - Relationship between Spinal Cord Atrophy and Brain Cortical Lesions in Primary-Progressive MS
07:30 AM - 11:00 AM	Abstract	138 - The Neurofunctional Basis of Sensorimotor Preservation in Multiple Sclerosis Victoria Leavitt, PhD, FAAN
07:30 AM - 11:00 AM	Abstract	139 - Normal appearing white matter injury in MS is affected by the distance to the nearest cortical lesion Nikolaos Evangelou, PhD
07:30 AM - 11:00 AM	Abstract	140 - Level of Homocysteine, Homocysteine Thiolactone and Antibodies against N-homocysteinylated Proteins in Patients with Multiple Sclerosis Justin Murphy, MD
07:30 AM - 11:00 AM	Abstract	141 - Smoking Cessation and Disability Progression in Multiple Sclerosis: an Observational Cohort Study Cris S. Constantinescu, MD, PhD
07:30 AM - 11:00 AM	Abstract	142 - Serum Lipid and Antiphospholipid Antibodies Profiles in Different Phases of Multiple Sclerosis Tatiana Koudriavtseva, MD
07:30 AM - 11:00 AM	Abstract	143 - Multiple Sclerosis and Premorbid Risk Behaviour: Association Is Not Necessarily Causation Christopher H. Hawkes, MD, Bsc, FRCP, FAAN
07:30 AM - 11:00 AM	Abstract	144 - Vitamin D and Multiple Sclerosis: Are We Still in the Dark? Michael Douglas, MD
07:30 AM - 11:00 AM	Abstract	145 - Vitamin D Deficiency in Multiple Sclerosis: Possible Influence of Circulating Vitamin D Binding Protein Levels. Suhail Al-Shammri, FRCPC, FAAN
07:30 AM - 11:00 AM	Abstract	146 - Modulating effects of WT1 on the relationship between interferon-? and vitamin D levels in the patients with multiple sclerosis
07:30 AM - 11:00 AM	Abstract	147 - The Role of Vitamin D in Optic Neuritis - An Update Jodie Burton, MD, FAAN
07:30 AM - 11:00 AM	Abstract	148 - Vitamin D, B-Cell Immunoreactivity, and B-Cell Phenotypes in Cerebrospinal Fluid of Patients with Multiple Sclerosis Brigitte Wildemann, MD
07:30 AM - 11:00 AM	Abstract	149 - Dietary saturated fatty acids promote differentiation of Th1 and Th17 cells and aggravate neuroinflammation
07:30 AM - 11:00 AM	Abstract	150 - Sodium intake is associated with increased disease activity in multiple sclerosis Mauricio F. Farez, MD
07:30 AM - 11:00 AM	Abstract	151 - Identification of Clostridium perfringens epsilon toxin as a candidate trigger for new lesion formation in Multiple Sclerosis Timothy K. Vartanian, MD, PhD
07:30 AM - 11:00 AM	Abstract	152 - Effects of a Low Fat Plant Based Diet in Multiple Sclerosis (MS): Results of a 1- Year Long Randomized Controlled (RC) Study Vijayshree Yadav, MD, FAAN
07:30 AM - 11:00 AM	Abstract	153 - Expression of Multiple Sclerosis Susceptible Loci genes may assist in Diagnostic Decision Making Michael Gurevich
07:30 AM - 11:00 AM	Abstract	154 - A Multiple Sclerosis-associated single nucleotide polymorphism in the MERTK receptor is correlated with altered MERTK expression Trevor J. Kilpatrick, MBBS, PhD
07:30 AM - 11:00 AM	Abstract	155 - Is it worth to study families with Multiple Sclerosis (MS)? The case of a novel rare variant in a novel unexpected interferon-stimulated gene. Filippo Martinelli Boneschi
07:30 AM - 11:00 AM	Abstract	156 - CD58 and multiple sclerosis: genetic association, gene expression and prognostic value Michael Hecker, PhD
07:30 AM - 11:00 AM	Abstract	157 - An analysis of novel antibody repertoires in patients with Multiple Sclerosis: Do particular antibody genes recognize gray matter cellular targets? Ann Ligocki
07:30 AM - 11:00 AM	Abstract	158 - Molecular Network of ChIP-Seq-Based EBNA1-Target Cellular Genes Supports Biological Implications of EBV Persistence in Multiple Sclerosis Jun-ichi Satoh, MD, PhD
07:30 AM - 11:00 AM	Abstract	159 - Gustatory Dysfunction in Multiple Sclerosis Richard L. Doty, PhD, FAAN
07:30 AM - 11:00 AM	Abstract	160 - Multiple Sclerosis Reported Fatigue: Obstructive Sleep Apnea & Abnormalities in Sleep Architecture in a Community Cohort Mark Gudesblatt, MD
07:30 AM - 11:00 AM	Abstract	161 - Visual Field Defects in Multiple Sclerosis and Related Disorders Dong Joo Yun
07:30 AM - 11:00 AM	Abstract	162 - Multiple Sclerosis Exacerbation Presenting as Stress Cardiomyopathy Tyler Webb, MD
07:30 AM - 11:00 AM	Abstract	163 - Headache in Multiple Sclerosis: Features and Implications for Disease Management Jessica Wilcox, MD
07:30 AM - 11:00 AM	Abstract	164 - Neuropathic Pain in Multiple Sclerosis: a Contact Heat Evoked Potential Stimulator (CHEPS) Evaluation
07:30 AM - 11:00 AM	Abstract	166 - Multiple Sclerosis Compromises Various Aspects of Female Sexual Function Julia Koehn, MD
07:30 AM - 11:00 AM	Abstract	167 - Head-Up Tilt Test, R-R Interval Variation and Sympathetic Skin Response in the Assessment of the Autonomic Nervous System of Patients With Multiple Sclerosis Hizir Ulvi, MD
07:30 AM - 11:00 AM	Abstract	168 - Metabolic Syndrome and Disability in Multiple Sclerosis: A Retrospective Study Idanis Berrios Morales, MD
07:30 AM - 11:00 AM	Abstract	169 - Multiple Sclerosis and Stroke Eleanor Sung
07:30 AM - 11:00 AM	Abstract	170 - Prevalence of Thyroid Disease in a Multiple Sclerosis Clinic Cohort Donald A. Barone, DO
07:30 AM - 11:00 AM	Abstract	171 - A study of insulin resistance in multiplesclerosis subjects and healthy controls Myla D. Goldman, MD, MSC, FAAN
07:30 AM - 11:00 AM	Abstract	172 - Multiple Sclerosis Patients with Allergies Demonstrate Better Physical Outcomes but Worse Psychological Symptoms. Sahil Gupta, MD
07:30 AM - 11:00 AM	Abstract	173 - Right under our noses: olfactory pathology in central nervous system demyelinating diseases Gabriele C. De Luca, MD, DPhil, FAAN
07:30 AM - 11:00 AM	Abstract	174 - Deterioration or Improvement of Depression in Women is Associated with Site and Size of Multiple Sclerosis Lesions Klemens Winder, MD
07:30 AM - 11:00 AM	Abstract	175 - Functional Limitations Associated with Multiple Sclerosis: Findings from the US Medical Expenditure Panel Survey Joseph Menzin, PhD
07:30 AM - 11:00 AM	Abstract	176 - Increased Incidence of Breast Cancer in Multiple Sclerosis: The Influence of Vitamin D and Estrogen in MS-Breast Cancer Concordance Jacquelyn Laplant
07:30 AM - 11:00 AM	Abstract	177 - Smoking in Multiple Sclerosis Patients is Negatively Associated with Patient Perceived Psychosocial Factors
07:30 AM - 11:00 AM	Abstract	178 - Risk of Mood Changes with High Dose Corticosteroid Treatment for Demyelinating Event in Multiple Sclerosis Sarah A. Morrow, MD, MSC, FRCPC, FAAN
07:30 AM - 11:00 AM	Abstract	179 - Patient and Caregiver Quality of Life in Psychogenic Non-Epileptic Seizures Compared to Epileptic Seizures Ioannis Karakis, MD, FAAN
07:30 AM - 11:00 AM	Abstract	180 - Impact of Seizure Frequency Reduction on Health-Related Quality of Life Among Clinical Trial Subjects with Refractory Partial-Onset Seizures: A Pooled Analysis of Phase III Clinical Trials of Eslicarbazepine Acetate
07:30 AM - 11:00 AM	Abstract	182 - STOP-BANG Screening for Obstructive Sleep Apnea in Epilepsy Joon Y. Kang, MD
07:30 AM - 11:00 AM	Abstract	183 - Effects of Lacosamide on Sleep Parameters in Healthy Subjects: Results from an Open-label Study
07:30 AM - 11:00 AM	Abstract	184 - Systematic Review of the Impact of Rapid Eye Movement Sleep on Seizure Frequency Marcus Ng, MD
07:30 AM - 11:00 AM	Abstract	185 - Do antidepressants make seizures more or less likely in focal epilepsy patients undergoing elective EEG monitoring? Alyssa Brandt
07:30 AM - 11:00 AM	Abstract	186 - Does Vitamin D Use Alter Seizure Collections During Elective Adult Inpatient Video EEG Monitering? Alyssa Brandt
07:30 AM - 11:00 AM	Abstract	187 - Prevalence Of Metabolic Syndrome In Valproate-Treated Adult Patients With Epilepsy Aleksei Rakitin, MD
07:30 AM - 11:00 AM	Abstract	189 - The Effect of Valproate and Lamotrigine Monotherapy on Bone Health in Adult Epileptic Patients Mohammad S. Alhalabi, MD, FAAN
07:30 AM - 11:00 AM	Abstract	190 - Response-driven Models based on MRI and SPECT findings on Hippocampus for Lateralization of Temporal Lobe Epilepsy
07:30 AM - 11:00 AM	Abstract	192 - Magnetic Resonance Grading of Hippocampal Sclerosis in Temporal Lobe Epilepsy Patients Using an Equilibrium Model
07:30 AM - 11:00 AM	Abstract	193 - Cerebral Hyperperfusion and Vasodilatory Changes in Acute Seizure - Report of Three Cases Balaji Krishnaiah, MD, FAAN
07:30 AM - 11:00 AM	Abstract	194 - Quantitative Analyses of EEG with Special Electrodes in TGA Patients
07:30 AM - 11:00 AM	Abstract	196 - Is presurgical MEG useful in intractable temporal lobe epilepsy?
07:30 AM - 11:00 AM	Abstract	197 - Validation of Magnetoencephalography (MEG) as Presurgical Evaluaiton Tool in Pediatric Patients With Localization-Related Intractable Epilepsy. Helen Barkan, MD, PhD
07:30 AM - 11:00 AM	Abstract	198 - Comparison of Diagnostic Methods for Optimizing Epilepsy Surgery Outcome Including Magnetoencephalography William Boles, MD
07:30 AM - 11:00 AM	Abstract	199 - Circle of Willis, cerebral blood flow, and white matter hyperintensities in migraine Brett L. Cucchiara, MD
07:30 AM - 11:00 AM	Abstract	200 - F MRI analysis in Chronic Migraine: preliminary report Licia Grazzi, MD
07:30 AM - 11:00 AM	Abstract	201 - White Matter Microstructure Abnormalities in Paediatric Migraine Patients: In-Vivo Measures of Brain Hyperexcitability?
07:30 AM - 11:00 AM	Abstract	203 - Mid-Life Migraine and Late-Life Movement Disorder Symptoms: AGES-Reykjavik Study Ann Scher, PhD, FAAN
07:30 AM - 11:00 AM	Abstract	204 - Does the new International Classification of Headache Disorders will affect the Prevalence of Aura in patients with Migraine ? Hossein Ansari, MD, FAAN
07:30 AM - 11:00 AM	Abstract	205 - Barriers to Chronic Migraine Care: Results of the CaMEO (Chronic Migraine Epidemiology & Outcomes) Study Dawn C. Buse, PhD
07:30 AM - 11:00 AM	Abstract	206 - Association of the long pentraxin PTX3 gene polymorphism (rs3815627) with migraine in Iranian population Alireza Zandifar, MD
07:30 AM - 11:00 AM	Abstract	207 - Sinking Bone Flap Causing Paradoxical Orthostatic Headaches Mitra Assadi Khansare, MD, FAAN
07:30 AM - 11:00 AM	Abstract	208 - Investigation of Chemokine Receptor CCR2V64Il Gene Polymorphism and Migraine in Iranian Population Alireza Zandifar, MD
07:30 AM - 11:00 AM	Abstract	209 - Idiopathic Intracerebral Hypertension (IIH)/pseudotumor: Removing less CSF is best
07:30 AM - 11:00 AM	Abstract	210 - Peri Ictal Headache In Epilepsy Natarajan Visvanathan, MD, DM, FAAN
07:30 AM - 11:00 AM	Abstract	211 - Validating a Definition of Alcohol Sensitivity in Women with Migraine Qinyi Jiang
07:30 AM - 11:00 AM	Abstract	212 - Retrospective analysis of the predictors of successful posterior fossa decompression in patients with headaches attributed to chiari malformation Naresh Mullaguri, MD
07:30 AM - 11:00 AM	Abstract	213 - A Nutrition Intervention for Migraines Anne E. Bunner, PhD
07:30 AM - 11:00 AM	Abstract	214 - Individualized Pharmacogenetic Testing Improves Mood and Anxiety Treatment Outcomes in Chronic Migraine Patients Sandeep Vaishnavi, MD, PhD
07:30 AM - 11:00 AM	Abstract	215 - A Live Patient Simulation Model to Effectively Manage Difficult Headache Patients Fermina A. Pirmohamed, MD
07:30 AM - 11:00 AM	Abstract	216 - Chronic Migraine with Medication Overuse is Associated with Low Cognitive Reserve
07:30 AM - 11:00 AM	Abstract	217 - Bilateral Pain Hypersensitivity Over The Trigeminal Region And Dental Deafferentations In Patients With Classical Trigeminal Neuralgia Nathalie Guy Renouil, MD
07:30 AM - 11:00 AM	Abstract	218 - Diffusion Tensor Imaging in PSEN1-Related Spastic Paraparesis Reveals Widespread White Matter Abnormalities
07:30 AM - 11:00 AM	Abstract	219 - Shared Vulnerability of Two Synaptically-Connected Medial Temporal Areas to Age and Cognitive Decline: A 7T MRI Study Geoffrey A. Kerchner, MD, PhD
07:30 AM - 11:00 AM	Abstract	220 - White Matter Disease in Behavioral Variant Frontotemporal Dementia Correlates with Risk-Taking Behavior John Powers
07:30 AM - 11:00 AM	Abstract	221 - The Symmetric And Asymmetric Variant Of Microvascular White Matter Disease
07:30 AM - 11:00 AM	Abstract	222 - Voxel-based Morphometry Reveals Gray Matter Loss in Patients with Paget's Disease of the Bone Carrying SQSTM1 Gene Mutations Innocenzo Rainero, MD, PhD
07:30 AM - 11:00 AM	Abstract	223 - Regional Brain Differences in Cortical Thickness between Patients with Amnesic Mild Cognitive Impairment and Alzheimer`s Disease Dementia Ignacio Demey, MD, PhD
07:30 AM - 11:00 AM	Abstract	224 - Hippocampal Subfield Analysis in MCI patients: Comparing FreeSurfer on 3T MRI with Hand Segmentation on 7T Data Salil Soman, MD
07:30 AM - 11:00 AM	Abstract	225 - Functional Language Lateralization Of Primary Progressive Aphasia Variants Zachary Miller, MD
07:30 AM - 11:00 AM	Abstract	226 - A Cross-Culturally Valid Assessment of Object Semantics Bonnie Breining
07:30 AM - 11:00 AM	Abstract	227 - Neural Correlates of Sentence Repetition in the Logopenic Variant of Primary Progressive Aphasia Drew Goldberg
07:30 AM - 11:00 AM	Abstract	228 - Predictors of Recovery of Chronic Aphasia Aarushi Suneja, MD
07:30 AM - 11:00 AM	Abstract	229 - Syntactic Processing Skills in the Three Variants of PPA Rajani Sebastian, PhD
07:30 AM - 11:00 AM	Abstract	230 - Language networks imaging in Primary Progressive Aphasia in a Latin population Ismael Calandri, MD
07:30 AM - 11:00 AM	Abstract	231 - Impairment in Sentence Comprehension in Patients with the Behavioral Variant of Frontotemporal Degeneration (bvFTD) Rebecca B. Williams
07:30 AM - 11:00 AM	Abstract	232 - 18F-FDG-PET metabolic patterns in the semantic variant of PPA: Functional/clinical correlations. Single-subject 18F-FDG-PET beyond MRI Daniela Perani, MD
07:30 AM - 11:00 AM	Abstract	233 - Sensitivity of Consensus Criteria in the Quantitative Classification of Primary Progressive Aphasia Meredith Wicklund, MD, FAAN
07:30 AM - 11:00 AM	Abstract	234 - Bilingualism and language networks in the semantic variant of primary progressive aphasia. Ismael Calandri, MD
07:30 AM - 11:00 AM	Abstract	235 - Correlation between Cortical Thickness Measurements from Magnetic Resonance Imaging and Cognitive Performance on Episodic and Semantic Memory Tests Ignacio Demey, MD, PhD
07:30 AM - 11:00 AM	Abstract	236 - Preservation of Spatial Function: Role in Differential Diagnosis of Behavioral Variant Frontotemporal Dementia Anneliese Radke
07:30 AM - 11:00 AM	Abstract	237 - Validation of the Dynamic Affect Recognition Test (DART): Behavior and Anatomy in Neurodegenerative Disease Anneliese Radke
07:30 AM - 11:00 AM	Abstract	238 - Cognitive Deficits of Large-Vessel and Small-Vessel Vascular Dementia Ju-Young Na
07:30 AM - 11:00 AM	Abstract	239 - White Matter Disease and Cognitive Impairment in FMR1 Premutation Carriers Christopher M. Filley, MD, FAAN
07:30 AM - 11:00 AM	Abstract	240 - Age Effects on the Neural Basis of Self-Generation in Verbal Paired Associate Learning Jerzy P. Szaflarski, MD, PhD, FAAN
07:30 AM - 11:00 AM	Abstract	241 - Accentuated brain responses during semantic object memory retrieval in amnestic mild cognitive impairment as measured by event-related potentials Hsueh-Sheng Chiang, MD, PhD
07:30 AM - 11:00 AM	Abstract	242 - Relationship Between Dementia Severity Ratings And Memory Accuracy Vs. Certainty Matthew Harris
07:30 AM - 11:00 AM	Abstract	243 - Changes of Face Recognition after Medial Temporal Lobe Resection Masoud Majed, MD
07:30 AM - 11:00 AM	Abstract	244 - A Case of Perioperative Stroke caused by Tumour Embolus. Stella E. Hughes, MD
07:30 AM - 11:00 AM	Abstract	245 - Thrombosis of the Vein of Trolard Secondary to Renal Minimal Change Disease: A Case Report and Literature Review Marcelo Rocha, MD, PhD
07:30 AM - 11:00 AM	Abstract	246 - A case of akinetopsia Wolfgang Grisold, MD, FAAN
07:30 AM - 11:00 AM	Abstract	248 - A case series of non-bacterial thrombotic endocarditis associated with gynecological malignancies Alice J. Schabas, MD
07:30 AM - 11:00 AM	Abstract	249 - Pituitary Apoplexy Presenting as Anterior Choroidal Artery Territory Infarct: A Case Report Sasikanth Gorantla, MD
07:30 AM - 11:00 AM	Abstract	250 - Lacunar Infarct Presenting Like Axillary Nerve Lesion: A case report
07:30 AM - 11:00 AM	Abstract	251 - Case of Neurosyphilis Presenting as MoyaMoya Syndrome Saima Ali, MD
07:30 AM - 11:00 AM	Abstract	252 - Two Cases of Malignant Cerebral Edema Related to Systemic Lupus Erythematous Lauren Koffman, DO, MS
07:30 AM - 11:00 AM	Abstract	253 - Case Report: Multiple Scattered Ischemic and Hemorrhagic Strokes after Transarterial Chemoembolization for Hepatocellular Carcinoma Alhamza Al-Bayati, MD
07:30 AM - 11:00 AM	Abstract	256 - Generalized Dilative Arteriopathy without Myopathy: A New Phenotype of Pompe Disease
07:30 AM - 11:00 AM	Abstract	257 - Brain herniation due to mitochondrial encephalomyopathy, lactic acidosis, stroke like events (MELAS) with 3256 mutation responsive to decompressive craniotomy Chunmei Cui, MD
07:30 AM - 11:00 AM	Abstract	259 - Synthetic Cannabis and Acute Ischemic Stroke Miya Bernson-Leung, MD
07:30 AM - 11:00 AM	Abstract	260 - A novel heterozygous c.164G>C mutation in the exon 2 of the NOTCH3 gene causing Cadasil Raphael Hourez, MD, PhD
07:30 AM - 11:00 AM	Abstract	261 - Amusia: Unique presentation of stroke Charu Ramchandani, MD
07:30 AM - 11:00 AM	Abstract	263 - Right hemispheric acute ischemic stroke secondary to right common carotid artery free floating thrombus due to hypercoagulable state in an otherwise healthy 48-year-old woman. Karen D. Orjuela, MD, FAAN
07:30 AM - 11:00 AM	Abstract	264 - Uncomon Cause Stroke: Thalamic Stroke As Initial Presentation Of Dunnigan Familial Partial Lipodystrophy (FPLD) Fatai Radji, MD
07:30 AM - 11:00 AM	Abstract	266 - “Pseudostroke”: Clinically Diagnosed Ischemia Shown to Be Multiple Sclerosis at Autopsy, A Case Report Gulshan Uppal, MD, FAAN
07:30 AM - 11:00 AM	Abstract	267 - Delayed Cortical Blindness after Cardiac Arrest Anibal Lugo, MD
07:30 AM - 11:00 AM	Abstract	268 - Case Report - Cerebral Amyloid Angiopathy with Granulomatous Angiitis Ali Saeed, MD
07:30 AM - 11:00 AM	Abstract	269 - Paradoxical Cerebral Embolism from Thrombolysis of a Clotted Arteriovenous Graft Umang M. Shah, MD
07:30 AM - 11:00 AM	Abstract	270 - A Rare Association between Ulcerative Colitis and Bilateral Thalamic Stroke
07:30 AM - 11:00 AM	Abstract	271 - Monocular diplopia after left posterior cerebral artery territory infarction
07:30 AM - 11:00 AM	Abstract	272 - Rapid High Volume CSF Loss: A New Cause of Coma Minjee Kim, MD
07:30 AM - 11:00 AM	Abstract	274 - Visit-to-visit Systolic Blood Pressure Variability Predicts All-Cause and Cardiovascular Mortality after Lacunar Infarct Gary K. Lau, MBBS
07:30 AM - 11:00 AM	Abstract	275 - Medicare's New Two Midnight Rule for In-patient Status Admission Applied to Transient Ischemic Attack Patients Predicted by Hypertension History and Age Maria O. Chavez, MD
07:30 AM - 11:00 AM	Abstract	276 - High Burden of Brain Microvascular Disease in Difficult-to-Control Hypertension Maria C. Zurru, MD
07:30 AM - 11:00 AM	Abstract	277 - Comparison of classical risk factors, lypids, stress and depression among patients with first ischemic stroke and acute myocardial infarction in a Center from Buenos Aires.
07:30 AM - 11:00 AM	Abstract	278 - Analysis of Comorbidities in Ischemic Stroke Patients Thomas Cochran
07:30 AM - 11:00 AM	Abstract	279 - Low Density Lipoprotein Receptor Related Protein-1 and 6 Gene Variants and Ischemic Stroke Risk Andrea Harriott, MD
07:30 AM - 11:00 AM	Abstract	281 - Analysis of the Relation Between Chronic Kidney Disease and Acute Ischemic Stroke. Patricio Blaya, MD
07:30 AM - 11:00 AM	Abstract	282 - The Relationship between Leukocytosis and Time to Neurodeterioration Amelia K. Boehme, PhD
07:30 AM - 11:00 AM	Abstract	283 - Incidence, Seasonality and Comorbidity in Vestibular Neuritis Ivan Adamec
07:30 AM - 11:00 AM	Abstract	284 - Retinal Ganglion Cell Injury Precedes RNFL loss In Acute Optic Neuritis John R. Guy, MD
07:30 AM - 11:00 AM	Abstract	285 - Gordon Holmes 100 years later: Cortical folding predicts retinotopic organization Noah Benson
07:30 AM - 11:00 AM	Abstract	286 - Retinal Structure and Function in Adults with Refractory Complex Partial Seizures (rCPS) Treated with Vigabatrin: Initial Results of the Sabril Vision Study Robert T. Wechsler, MD, PhD, FAAN
07:30 AM - 11:00 AM	Abstract	287 - Vision-Based Concussion Testing in a Youth Ice Hockey Cohort: Effects of Age and Visual Crowding Jennifer Morganroth, MD, MD/MBA
07:30 AM - 11:00 AM	Abstract	289 - Quantitative Video-oculography to Differentiate Stroke from Vestibular Neuritis in Acute Vertigo?Vestibulo-ocular Reflex Gain Distributions and Optimal Test Thresholds for Diagnosis Ali Saber Tehrani, MD
07:30 AM - 11:00 AM	Abstract	290 - Susac's Syndrome: Five Cases with Predominant Branch Retinal Artery Occlusion Thomas Seifert, MD
07:30 AM - 11:00 AM	Abstract	291 - Correlation of Acute Phase Reactants and Temporal Artery Biopsy (TAB) in Patients with Giant Cell Arteritis (GCA) Padmaja Sudhakar, MD
07:30 AM - 11:00 AM	Abstract	292 - Clinical and electrophysiological photostress recovery times in distinguishing demiyelinating optic neuritis and maculopathy Fethi Idiman, MD
07:30 AM - 11:00 AM	Abstract	293 - A Retrospective study of Chronic Relapsing Inflammatory Optic Neuropathy (CRION) Padmaja Sudhakar, MD
07:30 AM - 11:00 AM	Abstract	294 - Eye movement features in rare hereditary parkinsonian syndromes
07:30 AM - 11:00 AM	Abstract	295 - Ocular Motility Disturbances in Orbitofacial Neurofibromatosis Type 1 Thomas M. Bosley, MD, FAAN
07:30 AM - 11:00 AM	Abstract	296 - Neurosurgical Cases with Cortical Vision Loss followed by Improvement Bonnie M. Keung, MD
07:30 AM - 11:00 AM	Abstract	297 - Optical Coherence Tomography Quadrant Analysis of Retinal Nerve Fiber Layer in Relapsing and Remitting Multiple Sclerosis John W. Rose, MD, FAAN
07:30 AM - 11:00 AM	Abstract	298 - Demyelinating Optic Chiasmopathy Due to Mycobacterium Haemophilum in a Patient with AIDS Alexander Merkler, MD
07:30 AM - 11:00 AM	Abstract	299 - Visual evoked potential and magnetic resonance imagine are more effective markers of multiple sclerosis progression than laser polarimetry with variable corneal compensation
07:30 AM - 11:00 AM	Abstract	300 - Presence of AQP4 Antibodies Correlates with Negative Outcome of Optic Neuritis Jana Lizrova
07:30 AM - 11:00 AM	Abstract	301 - Evidence of multi-domain mild cognitive impairment in Idiopathic Intracranial Hypertension Anat Kesler, MD
07:30 AM - 11:00 AM	Abstract	302 - ‘Ping-pong' gaze in Hypoglycemic Encephalopathy Saima Ali, MD
07:30 AM - 11:00 AM	Abstract	303 - Do Not Forget Susac Syndrome in Patients with Unexplained Acute Confusion Michael J. Star, MD
07:30 AM - 11:00 AM	Abstract	304 - Clinical utility of cervical vestibular evoked myogenic potential (VEMPc) in Ménière's disease Guillermo Videla, MD
07:30 AM - 11:00 AM	Abstract	305 - An unusual case of Idiopathic Intracranial Hypertension presenting with simultaneous IIIrd, VIth and V11th nerve palsies Akshat Katyayan, MD
07:30 AM - 11:00 AM	Abstract	306 - Restricted Diffusion Imaging In Active Seizure: A Case Report Adnan Subei, DO, FAAN
07:30 AM - 11:00 AM	Abstract	307 - Presence of AQP4 Antibodies Correlates with Negative Outcome of Optic Neuritis Jana Preiningerova, MD
07:30 AM - 11:00 AM	Abstract	308 - Diplopia and Esophoria Induced by Medial Thalamic Deep Brain Stimulation Barbara Changizi, MD
07:30 AM - 11:00 AM	Abstract	309 - Decline in perceptual motor speed and cognitive flexibility associated with regional patterns of FDG PET hypometabolism Alan Lerner, MD
07:30 AM - 11:00 AM	Abstract	310 - A fMRI Graph Theory Study of the Effect of Gender and Aging on Topology of Functional Brain Networks Gianna Carla Riccitelli
07:30 AM - 11:00 AM	Abstract	311 - Early Striatal Perfusion Deficits in Autosomal Dominant Alzheimer Disease Detected with Arterial Spin Labeled MRI. Eric M. McDade, DO
07:30 AM - 11:00 AM	Abstract	312 - The effect of age of onset on the brain functional connectivity in Alzheimer's disease: a graph analysis study Elisa Canu
07:30 AM - 11:00 AM	Abstract	315 - Decreased white matter NAA in Alzheimer's Disease Navid Seraji-Bozorgzad, MD
07:30 AM - 11:00 AM	Abstract	316 - Medial Parietal Cortex GABA Measurements in Alzheimer's Disease are Inversely Associated with Functional Response Novraj Dhanjal, MD
07:30 AM - 11:00 AM	Abstract	317 - Dorsolateral Prefrontal Cortex Modulation by Caudate Dopamine During a Working Memory Task in Parkinson Disease Joseph C. Masdeu, MD, PhD, FAAN
07:30 AM - 11:00 AM	Abstract	318 - Region specific alpha-band resting-state functional connectivity predicts focal cognitive deficits in Alzheimer's disease spectrum Kamalini G. Ranasinghe, MD, PhD
07:30 AM - 11:00 AM	Abstract	320 - Differences in 11C-PIB-PET Imaging Patterns In Patients With Alzheimer's Disease Without Microbleeds And Those With Cerebral Amyloid Angiopathy Yuichi Hayashi
07:30 AM - 11:00 AM	Abstract	321 - Association between Longitudinal Increases in Serum Glucose and Metabolic Decline in Azheimer's Disease-Related Brain Regions Christine Burns
07:30 AM - 11:00 AM	Abstract	322 - Effects of ?-amyloid load on white matter integrity in dementia with Lewy bodies Zuzana Nedelska, MD, PhD
07:30 AM - 11:00 AM	Abstract	325 - [18F]FDG PET Evidence Of Atypical Medial Temporal Lobe Dysfunction In Prodromal Alzheimer's Disease
07:30 AM - 11:00 AM	Abstract	326 - PIB-Positive PET in Individuals with Early- but Not Late-Onset Frontotemporal Dementia
07:30 AM - 11:00 AM	Abstract	327 - Cavum Septum Pellucidum in Symptomatic Retired Pro-football Players Raquel Gardner, MD
07:30 AM - 11:00 AM	Abstract	328 - Reliable Detection Of Striatal Amyloid With [18F] Flutemetamol: Validation With Postmortem Histopathology Thomas Beach
07:30 AM - 11:00 AM	Abstract	329 - Progressive Hippocampus Atrophy in Persons with Mild Cognitive Impairment: A Longitudinal MRI study Iryna Lobanova, MD, PhD
07:30 AM - 11:00 AM	Abstract	331 - Pathologic validation of the EADC-ADNI Harmonized Hippocampal Protocol Liana Apostolova, MD, FAAN
07:30 AM - 11:00 AM	Abstract	332 - Dementia with Lewy bodies: Pathological basis of the cingulate island sign Jonathan Graff-Radford, MD, FAAN
07:30 AM - 11:00 AM	Abstract	333 - Progressive Hippocampus Atrophy in Persons with Alzheimer's disease: A Longitudinal MRI study Iryna Lobanova, MD, PhD
07:30 AM - 11:00 AM	Abstract	334 - Genetic Variation within the Oxidative Phosphorylation Pathway in Stroke and Alzheimer's Disease Alessandro Biffi, MD
07:30 AM - 11:00 AM	Abstract	335 - Stereo-electroencephalography versus subdural grids and depth electrode placements: when to use which? Adetoun Musa, MD
07:30 AM - 11:00 AM	Abstract	336 - Critical Intraoperative Neurophysiologic Monitoring (IONM) Changes Associated with Patient Positioning Maneuvers Leslie H. Lee, MD, FAAN
07:30 AM - 11:00 AM	Abstract	337 - Does Intraoperative Neurophysiologic Monitoring (IONM) Cause Delays in Surgical Cases? Forough Ghavami, DO
07:30 AM - 11:00 AM	Abstract	339 - Post Resection Electro-corticography Predicts Seizure Outcome - A Multivariate Logistic Analysis Sonia N. Krish, MD
07:30 AM - 11:00 AM	Abstract	340 - The Predictive Value of Electrocorticography in Patients with Mesial Temporal Lobe Epilepsy Undergoing Selective Amygdalohippocampectomy Aline Herlopian, MD
07:30 AM - 11:00 AM	Abstract	341 - Refractory status epilepticus: a report of two cases to illustrate the significance of GAD antibody Ayaz M. Khawaja, MD
07:30 AM - 11:00 AM	Abstract	342 - NMDA Receptor Encephalitis Presenting as Partial Status Epilepticus. Case Report and Discussion Simona V. Proteasa, MD
07:30 AM - 11:00 AM	Abstract	343 - Is Rasmussen's Encephalitis a NMDA Encephalitis? A Case Report and Review of Literature Simona V. Proteasa, MD
07:30 AM - 11:00 AM	Abstract	344 - Intravenous Immunoglobulin Therapy for Late-Stage Rasmussen's Encephalitis: Long-Term Seizure Freedom Rahul H. Dave, MD, PhD

Faculty Disclosures
Tracy A. Glauser, MD	Dr. Glauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Glauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. The institution of Dr. Glauser has received research support from NIH. Dr. Glauser has received intellectual property interests from a discovery or technology relating to health care. Dr. Glauser has received publishing royalties from a publication relating to health care.
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Jeremy D. Schmahmann, MD, FAAN	Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Steven T. DeKosky, MD, FAAN	Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. DeKosky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail Pharamceuticls. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex, Inc. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up-To-Date. Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics .
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Alan J. Thompson, MD, FRCP, FAAN	No disclosure on file
Jose Biller, MD, FACP, FAHA, FAAN	Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
Marinos C. Dalakas, MD, FAAN	Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx,. Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda/Hyquvia. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Raphael Hourez, MD, PhD	No disclosure on file
Steven Shook, MD	Dr. Shook has nothing to disclose.
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Jouko I. Isojarvi, MD, PhD	No disclosure on file
Eduardo Nobile-Orazio, MD, PhD, FAAN	Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX, Belgium. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB, France. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Switzerland. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen, USA. The institution of Dr. Nobile-Orazio has received research support from Takeda/Shire.
Fabrizio Salvi, MD	No disclosure on file
Eva Havrdova, MD	Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Vijayshree Yadav, MD, FAAN	Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb Foundation. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono . The institution of Dr. Yadav has received research support from Department of Veterans Affairs. Dr. Yadav has received research support from NIH. Dr. Yadav has received research support from PCORI. Dr. Yadav has received research support from NMSS. The institution of Dr. Yadav has received research support from Department of Veterans Affairs. The institution of Dr. Yadav has received research support from Tykeson Family Foundation Endowed Professorship.
Michael V. Johnston, MD	No disclosure on file
Benjamin J. Osborne, MD, FAAN	Dr. Osborne has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Osborne has received publishing royalties from a publication relating to health care.
Dorothea A. Buck, MD	No disclosure on file
Deborah A. Lee, MD, PhD	No disclosure on file
P. James B. Dyck, MD, FAAN	Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Michael S. Okun, MD, FAAN	Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
John Hart, MD	The institution of Dr. Hart has received research support from Department of Defense.
Kenneth A. Levin, MD	No disclosure on file
Susan L. Perlman, MD	Dr. Perlman has nothing to disclose.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica.
Stefan M. Pulst, MD, FAAN	Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Marc Dinkin, MD	Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for WILSON ELSER MOSKOWITZ EDELMAN & DICKER LLP. Dr. Dinkin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Rehabilitation Alternative Services, Inc.. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for AMFS / Medical Experts Nationwide. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bekman, Marder, Hopper, Malarkey & Perlin, L.L.C.. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Northwestern Mutual. Dr. Dinkin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Young Conaway Stargatt & Taylor. Dr. Dinkin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Young and Conway . Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Luks, Santiello.
David E. Newman-Toker, MD, PhD, FAAN	The institution of Dr. Newman-Toker has received research support from NIH, AHRQ, AHA, Moore Foundation. Dr. Newman-Toker has received intellectual property interests from a discovery or technology relating to health care.
Adam B. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Thirty Madison. Dr. Cohen has received stock or an ownership interest from Thirty Madison.
Silva Markovic-Plese, MD, FAAN	Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Ana Recober-Montilla, MD	Dr. Recober-Montilla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Recober-Montilla has received intellectual property interests from a discovery or technology relating to health care.
Michael Levy, MD, PhD, FAAN	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Kelly Sullivan, PhD	Dr. Sullivan has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file
Christopher Ward	No disclosure on file
Thomas D. Bird, MD, FAAN	No disclosure on file
Gail H. Marracci, PhD	No disclosure on file
Brian C. Healy	The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Alhamza Al-Bayati, MD	No disclosure on file
Diego Torres-Russotto, MD, FAAN	Dr. Torres-Russotto has received personal compensation for serving as an employee of Movement Disorders Consulting, Inc. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for IPSEN. Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Your Nest Asset Solutions, LLC. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Bright Future Asset Solutions, LLC. The institution of Dr. Torres-Russotto has received research support from Merz.
Daniel Reich, MD, PhD	Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi-Genzyme. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with PeerView. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with AcademicCME. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Integrity. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi-Genzyme that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with American Brain Foundation that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Biohaven that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sana that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Merck KGaA EMD Serono that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Bristol-Meyers Squibb that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with ChemoCentryx that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Perceptive that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities.
Niels Bergsland	Prof. Bergsland has nothing to disclose.
Mark E. Landau, MD, FAAN	No disclosure on file
Tal Shany-Ur, PhD	No disclosure on file
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
William O. Tatum IV, DO, FAAN	Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities.
John E. Greenlee, MD, FAAN	Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
David S. Goldstein, MD, PhD	Dr. Goldstein has received publishing royalties from a publication relating to health care.
Orla Hardiman, MD, FRCP, FAAN	Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Timothy Lesnick	No disclosure on file
Matilde Inglese, MD, PhD	Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Christopher M. Filley, MD, FAAN	Dr. Filley has received personal compensation for serving as an employee of University of Colorado Press. Dr. Filley has received personal compensation for serving as an employee of Oxford University Press. Dr. Filley has received personal compensation for serving as an employee of Cambridge University Press . Dr. Filley has received personal compensation for serving as an employee of Elsevier, Inc.. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell LLP. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Evans Case LLP. The institution of Dr. Filley has received research support from Department of Defense. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care.
Chong S. Lee, MD, FRCPC	Dr. Lee has nothing to disclose.
Andrew H. Ahn, MD, PhD	Dr. Ahn has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Fred D. Lublin, MD, FAAN	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Kimford J. Meador, MD, FAAN	The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from Eisai. The institution of Dr. Meador has received research support from Medtronics. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
Maria Luisa Gorno Tempini, MD, PhD	The institution of Dr. Gorno Tempini has received research support from NIH.
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
John M. Bertoni, MD, PhD, FAAN	Dr. Bertoni has nothing to disclose.
William J. Litchy, MD, FAAN	Dr. Litchy has nothing to disclose.
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Michael R. Sperling, MD, FAAN	Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Jorge C. Kattah, MD, FAAN	Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm.
Edmond Teng, MD, PhD	Dr. Teng has received personal compensation for serving as an employee of Genentech. An immediate family member of Dr. Teng has received personal compensation for serving as an employee of Evidation Health. Dr. Teng has stock in F. Hoffman-La Roche. An immediate family member of Dr. Teng has stock in Evidation Health. Dr. Teng has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Teng has received intellectual property interests from a discovery or technology relating to health care.
Edward M. Manno, MD, FAAN	No disclosure on file
Jorge D. Correale, MD	Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
David H. Salat	David H. Salat has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuroimage. David H. Salat has received stock or an ownership interest from Niji. David H. Salat has received stock or an ownership interest from Smart Ion. The institution of David H. Salat has received research support from Renew.
Hossein Ansari, MD, FAAN	Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NOEMA Pharmaceutical . Dr. Ansari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BIOHAVEN Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioDelivery Sciences International, Inc. . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Ansari has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MedLegal Network. Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Litogation Legal insight ( LITILI). Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FOLAND, WICKENS, ROPER, HOFER & CRAWFORD, P.C.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society.
Jaime R. Lopez, MD	An immediate family member of Dr. Lopez has received personal compensation for serving as an employee of AbbVie. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Lopez has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical-legal consulting.
HaeWon Shin, MD	The institution of Dr. Shin has received research support from NIH RO1. The institution of Dr. Shin has received research support from NIH U Grant. The institution of Dr. Shin has received research support from UCB. The institution of Dr. Shin has received research support from Biogen. The institution of Dr. Shin has received research support from Neuropace.
Nizar Souayah, MD, FAAN	Dr. Souayah has received publishing royalties from a publication relating to health care.
Katya Rascovsky	No disclosure on file
Katherine P. Rankin, PhD	The institution of Dr. Rankin has received research support from Marcus Foundation.
Pierre Clavelou, MD, PhD	Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Francisco J. Quintana, PhD	Dr. Quintana has nothing to disclose.
Stephen G. Reich, MD, FAAN	Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Reich has received research support from ninds. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Daniel Weintraub	Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care.
Mark A. Ross, MD, FAAN	No disclosure on file
Murray Grossman, MD, FAAN	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
James W. Wheless, MD, FAAP, FAAN	Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aquestive. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Greenwich. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BioMarin. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelius.
Lauren Phillips, MD	Dr. Phillips has nothing to disclose.
Pooja Khatri, MD, FAAN	The institution of Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. The institution of Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Cris S. Constantinescu, MD, PhD	Dr. Constantinescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Constantinescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Constantinescu has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. The institution of Dr. Constantinescu has received research support from Nottingham University Hospital Charity.
Mark Gudesblatt, MD	No disclosure on file
Sarah A. Morrow, MD, MSC, FRCPC, FAAN	Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIogen Idec. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMDSerono/Merck. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for sanofi genzyme. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS/Celgene. The institution of Dr. Morrow has received research support from EMD Serono. The institution of Dr. Morrow has received research support from Novartis. The institution of Dr. Morrow has received research support from Roche. The institution of Dr. Morrow has received research support from Celgene.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Murray S. Flaster, MD, PhD	No disclosure on file
Naim I. Haddad, MD, FAAN	Dr. Haddad has nothing to disclose.
Marta Radaelli	Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme.
Fidias E. Leon-Sarmiento	No disclosure on file
William E. Klunk, MD, PhD	No disclosure on file
Kristine Yaffe, MD	Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Oscar L. Lopez, MD, FAAN	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck.
Kailash P. Bhatia, MD, FAAN	Dr. Bhatia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Bhatia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi. Dr. Bhatia has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDS . The institution of Dr. Bhatia has received research support from EU Horizon 2020.
Eric M. McDade, DO	Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzamend. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fondation Alzheimer. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. The institution of Dr. McDade has received research support from NIA. The institution of Dr. McDade has received research support from Eli Lilly. The institution of Dr. McDade has received research support from Hoffman-La Roche. The institution of Dr. McDade has received research support from Eisai. The institution of Dr. McDade has received research support from Eisai. Dr. McDade has received intellectual property interests from a discovery or technology relating to health care.
Stephan Zuchner, MD, FAAN	Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Kyle B. Womack, MD	No disclosure on file
Alexandru C. Barboi, MD	Dr. Barboi has nothing to disclose.
Christopher M. DeGiorgio, MD, FAAN	Dr. DeGiorgio has received intellectual property interests from a discovery or technology relating to health care.
Luisa Chiapparini, MD	No disclosure on file
S H. Subramony, MBBS, FAAN	Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fallonmedica. The institution of Dr. Subramony has received research support from Reata. The institution of Dr. Subramony has received research support from Retrotope. The institution of Dr. Subramony has received research support from Acceleron. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Pharnext. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from National Ataxia Foundation. The institution of Dr. Subramony has received research support from Friedreich Ataxia Research Alliance. The institution of Dr. Subramony has received research support from Muscular Dystrophy Association. The institution of Dr. Subramony has received research support from Univ of Rochester, MDA. The institution of Dr. Subramony has received research support from Virginia Commonwealth Univ (FDA, Wyck Foundation)). The institution of Dr. Subramony has received research support from Children's Hospital, Philadelphia (FDA). The institution of Dr. Subramony has received research support from Houston Methodist (NIH). The institution of Dr. Subramony has received research support from NIHR01 AR076060-01A1 . The institution of Dr. Subramony has received research support from NIH2R42HD089804-04 . The institution of Dr. Subramony has received research support from NIH R01 AR056973 . The institution of Dr. Subramony has received research support from FSHD Society. The institution of Dr. Subramony has received research support from AAVANTI BIO. The institution of Dr. Subramony has received research support from COHAV FL State Dept of Health.
Amy W. Amara, MD PhD	The institution of Dr. Amara has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics, Inc. The institution of Dr. Amara has received research support from Michael J Fox Foundation for Parkinson's Research . The institution of Dr. Amara has received research support from Biogen Idec. The institution of Dr. Amara has received research support from NIH.
Ludwig Kappos, MD, FAAN	The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care.
Michael L. Reed, PhD	The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Glenn E. Smith, MD, PhD	No disclosure on file
Donald A. Barone, DO	Dr. Barone has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vanda. Dr. Barone has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Serono. Dr. Barone has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National MS Society, Greater Delaware Valley Chapter.
Jeremy D. Slater, MD, FAAN	Dr. Slater has received personal compensation for serving as an employee of Stratus. Dr. Slater has stock in Zeto LLC.
Marcelo E. Bigal, MD, PhD	No disclosure on file
Halina Bartosik-Psujek	No disclosure on file
Moses Rodriguez, MD, FAAN	Dr. Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Victoria Leavitt, PhD, FAAN	Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Helmut Butzkueven, MD, MBBS	Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Tetsuo Ashizawa, MD, FAAN	An immediate family member of Dr. Ashizawa has received personal compensation for serving as an employee of Biopath Holdings. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cadence. Dr. Ashizawa has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. The institution of Dr. Ashizawa has received research support from NIH. The institution of Dr. Ashizawa has received research support from National Ataxia Foundation. The institution of Dr. Ashizawa has received research support from Myotonic Dystrophy Foundation. The institution of Dr. Ashizawa has received research support from Biogen.
Sachin Kedar, MD, FAAN	Dr. Kedar has received intellectual property interests from a discovery or technology relating to health care.
Drini Dobi, MD, PhD	No disclosure on file
Robert N. Schwendimann, MD, FAAN	No disclosure on file
Subasini Dash, MD	No disclosure on file
Sara A. Simpson, MD	No disclosure on file
Mehmet Senol	No disclosure on file
Pariwat Thaisetthawatkul, MD, FAAN	Dr. Thaisetthawatkul has nothing to disclose.
Mari Heininen-Brown, BA	No disclosure on file
Samuel Yip, MD, PhD	Dr. Yip has nothing to disclose.
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Mitra Assadi Khansare, MD, FAAN	No disclosure on file
Max J. Hilz, MD, PhD, FAAN	Dr. Hilz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Daniela Perani, MD	No disclosure on file
Ali Saber Tehrani, MD	Dr. Saber Tehrani has nothing to disclose.
Hamid Ebadi, MD	No disclosure on file
Clifton L. Gooch, MD, FAAN	Dr. Gooch has received publishing royalties from a publication relating to health care. Dr. Gooch has received publishing royalties from a publication relating to health care.
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Kejal Kantarci, MD	The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF.
Daniel J. Bonthius, MD	No disclosure on file
David S. Knopman, MD, FAAN	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Panayiotis N. Varelas, MD, PhD, FAAN	Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca -Alexion - Portola. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca- Alexion-Portola. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainsGate. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Varelas has received research support from Alexion. The institution of Dr. Varelas has received research support from Marinus. The institution of Dr. Varelas has received research support from Bayer. Dr. Varelas has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Rep to the RUC meeting with AAN. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving as a Speaker at the Annual Meeting with AAN. Dr. Varelas has a non-compensated relationship as a President - Past President with Neurocritical Care Society that is relevant to AAN interests or activities.
Venu Parachuri, MD	No disclosure on file
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Filterlex. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for 3D Communications. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Live. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Sciences International, Biogen, Click Therapeutics, Genzyme, Genentech, GW Pharmaceuticals, Immunic, Klein-Buendel Incorporated, Medimmune/Viela Bio, Medday, Merck/Serono, Neurogenesis LTD, Novartis, Osmotica Pharmaceuticals, Perception Neurosciences, Recursion/Cerexis Pharmaceuticals, Regeneron, Reckover Pharmaceuticals, Roche, TG Therapeutics.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics, AI therapeutics, AMO Pharma, Astra-Zeneca, Avexis Pharmaceuticals, Biolinerx, Brainstorm Cell Therapeutics, Bristol Meyers Squibb/Celgene, CSL Behring, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, Immunic, Karuna Therapeutics, Mapi Pharmaceuticals LTD, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics,Prothena Biosciences, Novartis, Regeneron, Sanofi-Aventis, Reata Pharmaceuticals, NHLBI (Protocol Review Committee), University of Texas Southwestern, University of Pennsylvania, Visioneering Technologies, Inc.. Dr. Cutter has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
David B. Watson, MD, FAAN	Dr. Watson has nothing to disclose.
Rohit Bakshi, MD, FAAN	Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. An immediate family member of Dr. Bakshi has received stock or an ownership interest from Biogen. The institution of Dr. Bakshi has received research support from BMS/Celgene. The institution of Dr. Bakshi has received research support from EMD Serono.
William J. Byrnes, MD	No disclosure on file
Jeff Guptill, MD, FAAN	Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has stock in argenx.
Duarte G. Machado, MD	Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Tamer Abdelhak, MD	No disclosure on file
Anthony E. Lang, MD, FAAN	Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acorda, AFFiRis, Biogen, Denali, Janssen, Intracellular, Kallyope, Lundbeck, Paladin, Retrophin, Roche, Sun Pharma, Theravance, and Corticobasal Degeneration Solutions, Sun Pharma, Medichem, Medtronic, AbbVie and Sunovion. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received publishing royalties from a publication relating to health care.
Antonia Ceccarelli, MD, PhD	No disclosure on file
Bonnie Glanz	The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Richard A. Hughes, MD	Dr. Hughes has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hansa Biopharma. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic.
Nerses Sanossian, MD, FAAN	Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma.
Craig Carroll, DO	No disclosure on file
Kenneth M. Heilman, MD, FAAN	Dr. Heilman has received publishing royalties from a publication relating to health care.
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Claudia F. Lucchinetti, MD, FAAN	The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Joseph E. Safdieh, MD, FAAN	Dr. Safdieh has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Safdieh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, P.C.. Dr. Safdieh has received publishing royalties from a publication relating to health care.
Timothy M. Miller, MD, PhD	Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Disarm Therapeutics. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen IDEC. Dr. Miller has received intellectual property interests from a discovery or technology relating to health care. Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Jerzy P. Szaflarski, MD, PhD, FAAN	Dr. Szaflarski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Michael Oshinsky, PhD	No disclosure on file
Emilia M. Gatto, MD, FAAN	Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for Bago Argentina. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bago. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen. Dr. Gatto has received research support from Roche. The institution of Dr. Gatto has received research support from CHDI.
Miya Bernson-Leung, MD	An immediate family member of Dr. Bernson-Leung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. The institution of Dr. Bernson-Leung has received research support from AAMC Northeast Group on Educational Affairs. The institution of an immediate family member of Dr. Bernson-Leung has received research support from NIH.
Olga Waln, MD	Dr. Waln has nothing to disclose.
Omar A. Khan, MD, PhD	No disclosure on file
Kenneth D. Laxer, MD, FAAN	Dr. Laxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK Lfe Sciences. Dr. Laxer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
Guillermo Videla, MD	No disclosure on file
Muhammad F. Suri, MD	Dr. Suri has nothing to disclose.
Robert C. Sergott, MD	Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Martin Goldstein, MD	No disclosure on file
Steven Jacobson	Steven Jacobson has nothing to disclose.
Lixin Zhang-Auberson, MD, PhD	No disclosure on file
Ingemar S. Merkies, MD	No disclosure on file
Jeremy C. Hobart, MD	No disclosure on file
Scott Przybelski	No disclosure on file
Stephen Sidney, MD, MPH	Dr. Sidney has nothing to disclose.
James C. Watson, MD	No disclosure on file
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. Dr. French has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Angelini that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Bright minds Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Arvelle that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Beacon biosignals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bloom Science Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with BridgeBio Pharma Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, scientific advisory board with Camp4 Therapeutics Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Scientific Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Coda Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Genentech Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eisai, that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eliem Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epihunter that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epiminder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Equilibre BioPharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Greenwich Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with GW Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Janssen Pharmaceutica that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Jazz Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Knopp Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Lipocine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with LivaNova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Longboard Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Lundbeck that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant,SAB with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuroelectrics USA Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuronetics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ono Pharmaceutical Co that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Otsuka Pharmaceutical Development that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Ovid Therapeutics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Paladin Labs Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LTY Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with SK Life Sciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with UCB Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, steering committee with Xenon that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Korro Bio Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Receptor that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Sage Therpeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Third Rock Ventures that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Pfizer that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Agrithera, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting with Autifony therapeutics, Unlimited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Baergic Bio that is relevant to AAN interests or activities.
Sherry Hsiang-Yi Chou, MD	Dr. Chou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL-Behring. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL-Behring. The institution of Dr. Chou has received research support from NIH/NINDS. The institution of Dr. Chou has received research support from University of Pittsburgh.
Sulev Haldre, PhD	No disclosure on file
Jeffery Gunter	The institution of Jeffery Gunter has received research support from NIH. Jeffery Gunter has received intellectual property interests from a discovery or technology relating to health care.
Jane Boggs, MD	The institution of Dr. Boggs has received research support from Liva Nova. Dr. Boggs has a non-compensated relationship as a Chairman PAB with Epilepsy Alliance North Carolina that is relevant to AAN interests or activities.
Tiffany W. Chow, MD, FAAN	No disclosure on file
Christopher H. Hawkes, MD, Bsc, FRCP, FAAN	Dr. Hawkes has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Jeffrey L. Bennett, MD, PhD, FAAN	Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon Therapeutics. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImCyse. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. The institution of Dr. Bennett has received research support from Alexion. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Giancarlo Comi, MD	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Maria C. Zurru, MD	No disclosure on file
Thomas M. Bosley, MD, FAAN	No disclosure on file
Masatoyo Nishizawa, MD	No disclosure on file
Andrea N. Leep Hunderfund, MD	The institution of Dr. Leep Hunderfund has received research support from American Medical Association. The institution of Dr. Leep Hunderfund has received research support from Kern National Network for Caring and Character in Medicine. Dr. Leep Hunderfund has received intellectual property interests from a discovery or technology relating to health care.
Wolfgang Grisold, MD, FAAN	No disclosure on file
Keith A. Josephs, Jr., MD, FAAN	Dr. Josephs has nothing to disclose.
Julian Benito-Leon	No disclosure on file
Mohammad S. Alhalabi, MD, FAAN	No disclosure on file
Osvaldo J. Nascimento, MD, PhD, FAAN	Dr. Nascimento has nothing to disclose.
Joseph Herbert, MD	No disclosure on file
Francesco Patti, MD	Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Helio Afonso G. Teive, MD	Dr. Teive has nothing to disclose.
Ann Marie Collier, MD, FAAN	Dr. Collier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW BIosciences. Dr. Collier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Collier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Collier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for LivaNova. Dr. Collier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK lifescience.
Eric R. Eggenberger, DO, FAAN	Dr. Eggenberger has nothing to disclose.
Steven M. Greenberg, MD, PhD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Washington University/IQVIA. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Greenberg has received research support from National Institutes of Health. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Scott E. Kasner, MD, FAAN	Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Diamedica. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Javelin. Dr. Kasner has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Kasner has received research support from Bristol-Myers Squibb. The institution of Dr. Kasner has received research support from Medtronic. The institution of Dr. Kasner has received research support from WL Gore.
Karen C. Johnston, MD, MSC	Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for University of Pittsburg. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mayo Clinic. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for University of California Irvine. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Johnston has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Johnston has received research support from NIH.
Antonio Toscano, MD	Dr. Toscano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme.
Nancy Monson	Nancy Monson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Nancy Monson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenrAb, Inc.. Nancy Monson has stock in GenrAb, Inc.. The institution of Nancy Monson has received research support from NIH. Nancy Monson has received intellectual property interests from a discovery or technology relating to health care.
Haatem M. Reda, MD	Dr. Reda has nothing to disclose.
Aline Herlopian, MD	Dr. Herlopian has nothing to disclose.
Mario Habek, MD	Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Vincenzo Brescia Morra, MD	Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Michelle Fabian, MD, FAAN	Dr. Fabian has nothing to disclose.
Vissia Viglietta, MD	No disclosure on file
Egemen Idiman, MD	No disclosure on file
Marina Boccardi, PhD	No disclosure on file
Geoffrey K. Aguirre, MD, PhD	Dr. Aguirre has received stock or an ownership interest from Nia therapeutics. The institution of Dr. Aguirre has received research support from Lion's Foundation. The institution of Dr. Aguirre has received research support from National Institutes of Health. The institution of Dr. Aguirre has received research support from Johnson and Johnson. The institution of Dr. Aguirre has received research support from Department of Defense.
Keith Vossel, MD	No disclosure on file
Charuta N. Joshi, MD	No disclosure on file
Nassim Zecavati, MD, FAAN	Dr. Zecavati has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AMA. Dr. Zecavati has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AAN. Dr. Zecavati has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for US Dept of Justice.
Soundarya Gowda, MD	Dr. Gowda has nothing to disclose.
Marlis Gonzalez-Fernandez, MD, PhD	No disclosure on file
Peter N. Riskind, MD, PhD	No disclosure on file
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Expert Witness. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb.
Brent P. Goodman, MD	Dr. Goodman has nothing to disclose.
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Jonathan H. McKinnon, MD	No disclosure on file
Carolina Ionete, MD	Dr. Ionete has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from Biogen. The institution of Dr. Ionete has received research support from NIH.
Goran Rakocevic, MD, FAAN	Dr. Rakocevic has nothing to disclose.
Michael G. Dwyer III, MD, PhD	Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Jaishri Blakeley, MD, FAAN	Dr. Blakeley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics.
R. John Leigh, MD	No disclosure on file
Ansgar Furst, PhD MS	No disclosure on file
Alex Rovira	Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofy. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Alex Rovira has stock in Tensor Medical.
Kristin Schwab	No disclosure on file
Innocenzo Rainero, MD, PhD	No disclosure on file
Edip M. Gurol, MD	The institution of Dr. Gurol has received research support from NIH/NINDS. The institution of Dr. Gurol has received research support from Boston Scientific Corporation. The institution of Dr. Gurol has received research support from AVID (a wholly owned subsidiary of Eli Lilly). The institution of Dr. Gurol has received research support from Pfizer.
Annachiara Cagnin	No disclosure on file
Joseph C. Masdeu, MD, PhD, FAAN	Dr. Masdeu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Moody Foundation. The institution of Dr. Masdeu has received research support from Biogen. The institution of Dr. Masdeu has received research support from Eli Lilly. The institution of Dr. Masdeu has received research support from Eisai. The institution of Dr. Masdeu has received research support from Novartis. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Anna D. Hohler, MD, FAAN	Dr. Hohler has nothing to disclose.
Elliot M. Frohman, MD, FAAN	Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Faze Medicine .
David S. Zee, MD	Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for florida legal. Dr. Zee has received publishing royalties from a publication relating to health care. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a lectuer with u of pittsburg physical therapy. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a lecturer with johms hopkins CME.
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viracta. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Lisa Hobson-Webb, MD, FAAN	An immediate family member of Dr. Hobson-Webb has received personal compensation for serving as an employee of G1 Therapeutics. Dr. Hobson-Webb has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley Publishing. The institution of Dr. Hobson-Webb has received research support from Sanofi Genzyme.
Janet C. Rucker, MD	Dr. Rucker has nothing to disclose.
Brian G. Weinshenker, MD, FAAN	Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. The institution of Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a speaker at internal meeting and symposium with Horizon.
John A. Detre, MD	Dr. Detre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hura Imaging. The institution of Dr. Detre has received research support from NIH. Dr. Detre has received personal compensation in the range of $500-$4,999 for serving as a grant proposal reviewer with NIH, VA, European Science Foundation,Deutsche Forschungsgemeinschaft.
Frederik Barkhof, MD, PhD	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Agnes Fromont	No disclosure on file
Joseph Duffy	No disclosure on file
Rui Sousa	No disclosure on file
Sven O. Jarius, MD	Dr. Jarius has nothing to disclose.
Maria V. Alvarez, MD	No disclosure on file
Meredith Wicklund, MD, FAAN	The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Leonard S. Li, MD, MBBS	No disclosure on file
Joanna E. O'Leary, MD	No disclosure on file
Ahmet Onur Keskin, MD	No disclosure on file
Samaneh Zandifar	No disclosure on file
Matthew Senjem	Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Geoffrey A. Kerchner, MD, PhD	Dr. Kerchner has received personal compensation for serving as an employee of F. Hoffmann-La Roche, Ltd.. Dr. Kerchner has stock in F. Hoffmann-La Roche, Ltd.. Dr. Kerchner has received publishing royalties from a publication relating to health care.
Magdalena Krbot Skoric	Magdalena Krbot Skoric has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Mohit Neema, MD	No disclosure on file
Ruchir Shah, MD	Dr. Shah has nothing to disclose.
Neill R. Graff-Radford, MD, FAAN	The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Novartis. The institution of Dr. Graff-Radford has received research support from AbbVie. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Joseph J. Higgins, MD, FAAN	No disclosure on file
Pierre Fayad, MD, FAHA, FAAN	Dr. Fayad has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fayad has received personal compensation in the range of $0-$499 for serving as a Member Data Safety & Monitoring Committee with NINDS.
Mushtaq H. Qureshi, MD	No disclosure on file
Michael Gurevich	No disclosure on file
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Gen Sobue, MD	Dr. Sobue has nothing to disclose.
John G. Whitesides	John G. Whitesides has received personal compensation for serving as an employee of UCB. John G. Whitesides has received stock or an ownership interest from UCB.
Ricardo F. Allegri, MD, PhD, FAAN	Dr. Allegri has nothing to disclose.
Omar Butt, MD	No disclosure on file
Israt Jahan, MD	No disclosure on file
Tuan H. Vu, MD	Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImmunAbs. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from Amylyx Pharma. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Annexon. The institution of Dr. Vu has received research support from Horizon. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Momenta. The institution of Dr. Vu has received research support from Immunovant.
Mona Bahouth, MD	The institution of Dr. Bahouth has received research support from American Heart Association. The institution of Dr. Bahouth has received research support from NIH.
Alejandra Amengual	No disclosure on file
Anmar Razak, MD	Dr. Razak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals.
Chutima Saipetch, MD	No disclosure on file
Elizabeth Sweeney	No disclosure on file
Kristina J. Lopez, MD	Dr. Lopez has nothing to disclose.
Panayiotis Mitsias, MD	Dr. Mitsias has nothing to disclose.
Zianka Fallil, MD	No disclosure on file
Julia Koehn, MD	No disclosure on file
Shannon N. Overs, MD	No disclosure on file
Richard M. Trosch, MD, FAAN	Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amneal . Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine . Dr. Trosch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Katherine L. Possin, PhD	Dr. Possin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ClearView Healthcare Partners. The institution of Dr. Possin has received research support from Quest Diagnostics. The institution of Dr. Possin has received research support from NIH. The institution of Dr. Possin has received research support from The Global Brain Health Institute. The institution of Dr. Possin has received research support from The Rainwater Foundation.
Erez Hanael	No disclosure on file
Halit Yasar	No disclosure on file
Takashi Inuzuka, MD, FAAN	No disclosure on file
Leonard H. Van den Berg, MD	The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Jonathan M. Beary, DO, FAAN	No disclosure on file
Mary Sano, PhD	Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Avenir. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen Idec. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for BioXcel. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for CogRx. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for F. Hoffman LaRoche. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Minerva Neuroscience. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for NovoNordisk. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Pfizer. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for vTv Therapeutics. Dr. Sano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos. Dr. Sano has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Alzheimer's Association. Dr. Sano has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Psychogeriatric Association.
Elia Haddad, MD	No disclosure on file
Griselda N. Russo, MD, PhD	No disclosure on file
Maria J. Bruzzone, MD	Dr. Bruzzone has nothing to disclose.
Meredith N. Braskie	No disclosure on file
Vibhav K. Bansal, MD, JD	No disclosure on file
Shahamat Tauhid, MD	Dr. Tauhid has nothing to disclose.
Alexander J. Beagle	No disclosure on file
Lisa M. Caylor, MD	No disclosure on file
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Lenore J. Launer, PhD	No disclosure on file
Scott Kolodny, MD	No disclosure on file
Christopher M. Goshgarian, MD	Dr. Goshgarian has nothing to disclose.
Michael T. Flink, DO, PhD	No disclosure on file
Christopher D. Anderson, MD, PhD, FAAN	The institution of Dr. Anderson has received research support from Bayer AG. The institution of Dr. Anderson has received research support from American Heart Association. The institution of Dr. Anderson has received research support from National Institutes of Health. An immediate family member of Dr. Anderson has received publishing royalties from a publication relating to health care.
Antonio G. Gallo, MD	No disclosure on file
Muhtesem Gedizlioglu, MD	No disclosure on file
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/ROche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Carlton Fields. Dr. Greenberg has stock in GenrAb. Dr. Greenberg has stock in Clene. The institution of Dr. Greenberg has received research support from Anokion. The institution of Dr. Greenberg has received research support from Regeneron. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Myla D. Goldman, MD, MSC, FAAN	Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Seronon. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen, IDEC. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Goldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ADAMAS. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmceuticals. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics Ltd., .
Tania Reyna, MD, FAAN	Dr. Reyna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Reyna has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Reyna has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Reyna has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics.
Ge Xiong, MD	Dr. Xiong has nothing to disclose.
L J. Greenfield, Jr., MD, PhD, FAAN	Dr. Greenfield has received publishing royalties from a publication relating to health care.
Barbara Changizi, MD	No disclosure on file
A J. Stoessl, MD, FAAN	No disclosure on file
Flavia Mattioli, MD	Dr. Mattioli has nothing to disclose.
Roberta Lanzillo	Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Yonas E. Geda, MD	The institution of Dr. Geda has received research support from NIH.
Luiza G. Piovesana, MD	No disclosure on file
Koon Ho Chan, MD, MBBS	No disclosure on file
Raymond T. Cheung, MD, FAAN	No disclosure on file
Catarina Quinzii Hirano, MD	No disclosure on file
Aleksei Rakitin, MD	No disclosure on file
Michael Cartwright, MD	Dr. Cartwright has received publishing royalties from a publication relating to health care.
Giovanni B. Frisoni, MD	No disclosure on file
Anat Kesler, MD	No disclosure on file
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Sat Dev Batish, PhD, FAAN	Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Edward Kim, MD	No disclosure on file
Jehuda P. Sepkuty, MD	No disclosure on file
Manikum Moodley, MD	Dr. Moodley has nothing to disclose.
Martina Absinta, MD	Dr. Absinta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Absinta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata Therapeutics. The institution of Dr. Absinta has received research support from International MS Alliance. The institution of Dr. Absinta has received research support from FRRB Early Career Award. The institution of Dr. Absinta has received research support from Cariplo Foundation.
Wenzhuan He, MD	Dr. He has nothing to disclose.
Marcus Ng, MD	The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Canada. Dr. Ng has received publishing royalties from a publication relating to health care.
Christina M. Nguyen, MD	No disclosure on file
QIANG DONG, PhD	No disclosure on file
Christine Burns	No disclosure on file
Lilyana M. Amezcua, MD, FAAN	Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for serono. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. The institution of Dr. Amezcua has received research support from National MS Society. The institution of Dr. Amezcua has received research support from Genentech. The institution of Dr. Amezcua has received research support from Medday. The institution of Dr. Amezcua has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Amezcua has received research support from NIH NINDS.
Varun Sethi, MD, PhD	No disclosure on file
Kartik Raghupathi	No disclosure on file
Viet Nguyen, MD	Dr. Nguyen has received personal compensation for serving as an employee of Biogen. Dr. Nguyen has stock in Biogen.
Veronica Gorden, BA	No disclosure on file
Leendert H. Visser, MD	No disclosure on file
Christina Azevedo, MD, FAAN	Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas Biopharma. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society. The institution of Dr. Azevedo has received research support from National Institutes of Health/National Institutes of Neurological Disorders and Stroke. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society.
Eric M. Reiman, MD	Dr. Reiman has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali, Green Valley, Zinfandel, and Takeda. Dr. Reiman has received stock or an ownership interest from Alkahest, Alzheon, Aural Analytics, Denali, and United Neuroscience.. Dr. Reiman has received intellectual property interests from a discovery or technology relating to health care. Dr. Reiman has received personal compensation in the range of $500-$4,999 for serving as a Member, National Advisory Council on Aging (NACA) with NIA.
Dhimant Dani, MD	Dr. Dani has nothing to disclose.
Anna Sorokin, MD	No disclosure on file
Leslie H. Lee, MD, FAAN	Dr. Lee has nothing to disclose.
Anat Achiron, MD, PhD, FAAN	Dr. Achiron has nothing to disclose.
Gerhard Winkler, MD	No disclosure on file
John Powers	No disclosure on file
John R. Guy, MD	No disclosure on file
Daniel J. Licht, MD	No disclosure on file
Christina Caon, RN, BS	Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
Edwin B. George, MD, PhD, FAAN	No disclosure on file
Mohammad Moussavi, MD	Dr. Moussavi has nothing to disclose.
Sungho K. Cho, MD	Dr. Cho has nothing to disclose.
Dieter Haering	Dieter Haering has received personal compensation for serving as an employee of Novartis.
Carole S. Scherling, PhD	No disclosure on file
Cesar C. Santos, MD	No disclosure on file
Eva Costa Arpin, MD	No disclosure on file
Mihir Parikh	No disclosure on file
Dennis N. Bourdette, MD, FAAN	Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Theresa A. Zesiewicz, MD	Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Heidi A. Bender, PhD	No disclosure on file
Adetoun Musa, MD	No disclosure on file
Maria Cristina Arci Santos	No disclosure on file
John Cole, MD	Dr. Cole has nothing to disclose.
Oezguer Yaldizli, MD	Dr. Yaldizli has nothing to disclose.
Thomas Beach	Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Ellen M. Mowry, MD, FAAN	Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BeCareLink, LLC. The institution of Dr. Mowry has received research support from Biogen. The institution of Dr. Mowry has received research support from Genentech. Dr. Mowry has received publishing royalties from a publication relating to health care.
Brad A. Racette, MD, FAAN	Dr. Racette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for American Regent. Dr. Racette has received personal compensation in the range of $500-$4,999 for serving as a advisory council with NIEHS.
Joyce A. Cramer	No disclosure on file
Josep O. Dalmau, MD, PhD, FAAN	Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Harry Vinters	No disclosure on file
Keith A. Johnson, MD	Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervGen. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. The institution of Dr. Johnson has received research support from National Institute on Aging. The institution of an immediate family member of Dr. Johnson has received research support from Alzheimer's Association. The institution of an immediate family member of Dr. Johnson has received research support from Eli Lilly and Co. The institution of Dr. Johnson has received research support from Eisai. The institution of an immediate family member of Dr. Johnson has received research support from Eisai.
Nathan P. Staff, MD, PhD, FAAN	Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.
Elysa Marco, MD	No disclosure on file
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has stock in NeuroRx.
Giovanni Savettieri, MD	No disclosure on file
Jane B. Allendorfer, PhD	An immediate family member of Dr. Allendorfer has received personal compensation for serving as an employee of Northport Health Services, LLC. The institution of Dr. Allendorfer has received research support from National Institutes of Health. The institution of Dr. Allendorfer has received research support from Evelyn F. McKnight Brain Institute. The institution of Dr. Allendorfer has received research support from LivaNova, Inc. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic. Dr. Allendorfer has received personal compensation in the range of $0-$499 for serving as a Examiner with University of Auckland. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International League Against Epilepsy. Dr. Allendorfer has a non-compensated relationship as a Scientific Program Committee Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Allendorfer has a non-compensated relationship as a Editorial Board Member with Epilepsy and Behavior Reports that is relevant to AAN interests or activities.
David E. Blum, MD	Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Franz Fazekas, MD	No disclosure on file
Catherine Cho, MD	Dr. Cho has nothing to disclose.
Ivan Adamec	Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zentiva.
Catherine Hosley, MD	No disclosure on file
Nicolas Collongues, MD	Nicolas Collongues, MD has nothing to disclose.
Marc F. Bataillard, MD	No disclosure on file
Federica Esposito	Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care.
Carla E. Santiago-Martinez	Ms. Santiago-Martinez has nothing to disclose.
Luka Vlahovic, MD	Dr. Vlahovic has nothing to disclose.
Zubeda B. Sheikh, MD	Dr. Sheikh has nothing to disclose.
Aisling Ryan, PhD, MB, FRCPI	Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Donna C. Graves, MD	Dr. Graves has nothing to disclose.
Veronica A. Bruno, MD	Dr. Bruno has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. The institution of Dr. Bruno has received research support from Paladin Labs. The institution of Dr. Bruno has received research support from Ipsen.
Mary M. Machulda, PhD	The institution of Dr. Machulda has received research support from NIH.
John M. Ringman, MD, FAAN	No disclosure on file
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Richard A. Rudick, MD, FAAN	Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Michael J. Schneck, MD, FAAN	An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Anthony Polazzo	No disclosure on file
Nizar Chahin, MD	No disclosure on file
Larus S. Gudmundsson, PhD	No disclosure on file
Rebecca Spain, MD, MSPH, FAAN	Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society.
Diego Cadavid, MD, FAAN	Dr. Cadavid has received personal compensation for serving as an employee of X4 Pharma. Dr. Cadavid has received personal compensation for serving as an employee of Fulcrum Therapeutics. Dr. Cadavid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvinas. Dr. Cadavid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata Therapeutics. Dr. Cadavid has received stock or an ownership interest from X4 Pharma. Dr. Cadavid has received stock or an ownership interest from Fulcrum Therapeutics.
Marcela Fiol	Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for merck. The institution of Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
Jonathan K. Smith, MD, FAAN	Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for OBT Law. Dr. Smith has a non-compensated relationship as a Committee Member, Clinical Neurophysiology CMOC Pilot, with ABPN that is relevant to AAN interests or activities.
Umang M. Shah, MD	No disclosure on file
Olga Ciccarelli, MD, PhD, FRCP	Prof. Ciccarelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Ciccarelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Ciccarelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Prof. Ciccarelli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEUROLOGY Journal.
Alberto R. Martinez, MD	No disclosure on file
Mauricio F. Farez, MD	Dr. Farez has nothing to disclose.
David H. Miller, MD, MBChB, FRCP	No disclosure on file
Jan Krasensky, MD	No disclosure on file
Peter S. Chin, MD	No disclosure on file
Stephen L. Yates, PhD	Dr. Yates has received personal compensation for serving as an employee of UCB Biosciences, Inc.. Dr. Yates has stock in UCB Biosciences, Inc..
Zhi-Jian Chen, MD	Dr. Chen has nothing to disclose.
Brigitte Capron, MD	No disclosure on file
Hizir Ulvi, MD	No disclosure on file
Michael J. Star, MD	Dr. Star has nothing to disclose.
Zhenyuan Wang, PhD	Dr. Wang has nothing to disclose.
Manuela Vaneckova	No disclosure on file
Iscia Lopes-Cendes, MD, PhD	No disclosure on file
Seby John, MD	Dr. John has nothing to disclose.
Corey McMillan, PhD	Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Hans D. Katzberg, MD, FAAN	An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Khaled Asi, MD	No disclosure on file
Fen Bao	No disclosure on file
Manuela Lema Bouzas	No disclosure on file
Sebastian F. Von Rosenstiel, MD, PhD	No disclosure on file
Paula C. Azevedo, MD	Dr. Azevedo has nothing to disclose.
Dana Horakova	Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Kimbra L. Kenney, MD, FAAN	Dr. Kenney has nothing to disclose.
Samuel E. Gandy, MD, PhD	No disclosure on file
Mohammed A. Hussain, MD	No disclosure on file
Nicole M. Warner, ARNP	No disclosure on file
Ali Saeed, MD	No disclosure on file
Tania F. Tayah, MD, FAAN	No disclosure on file
Gennaro Bussone	No disclosure on file
Andrew Cole, MD, FAAN	Dr. Cole has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANA. Dr. Cole has received publishing royalties from a publication relating to health care.
Philip A. Teal, MD	Dr. Teal has nothing to disclose.
Thomas P. Naidich, MD	No disclosure on file
Angela B. Deutschlander, MD	No disclosure on file
Dennis W. Dickson, MD	Dr. Dickson has nothing to disclose.
Ayesha Sherzai, MD	No disclosure on file
Zachary Miller, MD	Dr. Miller has nothing to disclose.
Machteld E. Hillen, MD, FAAN	The institution of Dr. Hillen has received research support from Genentech.
George R. Wilmot, MD, PhD	Dr. Wilmot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar Therapeutics. The institution of Dr. Wilmot has received research support from Friedrich Ataxia Research Alliance. The institution of Dr. Wilmot has received research support from National Ataxia Foundation. The institution of Dr. Wilmot has received research support from NIH. The institution of Dr. Wilmot has received research support from Reata. The institution of Dr. Wilmot has received research support from Biohaven Pharmaceuticals.
Sheryl Martin-Schild, MD, PhD, FAAN	No disclosure on file
Stephen J. Marks, MD	No disclosure on file
Peter J. Dyck, MD, FAAN	Dr. Dyck has nothing to disclose.
Ehud Lavi, MD	No disclosure on file
Maheep S. Virdi, MD	No disclosure on file
Alfredo Damasceno, MD	No disclosure on file
Louis C. Tan, MRCP	No disclosure on file
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Alexander Merkler, MD	Dr. Merkler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurohospitalist. Dr. Merkler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for n/a.
Amelia K. Boehme, PhD	Dr. Boehme has nothing to disclose.
Jera Kruja, MD	No disclosure on file
Rasha Abdel-Fahim	No disclosure on file
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics.
Felix Schmidt	No disclosure on file
Ahmad Riad Ramadan, MD	Dr. Ramadan has received publishing royalties from a publication relating to health care. Dr. Ramadan has received publishing royalties from a publication relating to health care.
Massimiliano Copetti	No disclosure on file
Ioannis Karakis, MD, FAAN	Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson.
Balaji Krishnaiah, MD, FAAN	Dr. Krishnaiah has received publishing royalties from a publication relating to health care.
Chunmei Cui, MD	No disclosure on file
Ritika Mahajan, MD	No disclosure on file
Dominique Monlezun, Jr	No disclosure on file
Shannon Sparrow	No disclosure on file
Orlando G. Barsottini, MD, PhD	Dr. Barsottini has nothing to disclose.
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Mohammed Rehman, DO	Dr. Rehman has nothing to disclose.
Kiran P. Maski, MD	An immediate family member of Dr. Maski has received personal compensation for serving as an employee of Sanofi Genzyme. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KemPharm. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hayes Legal Services. An immediate family member of Dr. Maski has stock in Sanofi Genzyme. The institution of Dr. Maski has received research support from Jazz Pharmaceuticals. The institution of Dr. Maski has received research support from NIH 5K23NS104267-2. The institution of Dr. Maski has received research support from Coverys. Dr. Maski has received publishing royalties from a publication relating to health care.
Benito P. Damasceno, MD, PhD	No disclosure on file
Gulshan Uppal, MD, FAAN	Dr. Uppal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Uppal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven.
Rajat Lahoria, MD	No disclosure on file
Tanis J. Ferman	Ms. Ferman has nothing to disclose.
Guangbin Xia, MD, PhD	No disclosure on file
Ari Breiner, MD	Dr. Breiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Breiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alynylam. Dr. Breiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe. The institution of Dr. Breiner has received research support from Muscular Dystrophy Canada.
Jorge Campos, MD	No disclosure on file
Arpita Chattopadhyay	No disclosure on file
Hakan Akgun	No disclosure on file
Gilles Defer, MD	Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Salman Azhar, MD	No disclosure on file
Rejean M. Guerriero, MD	No disclosure on file
Delphin Sallowm, MD	Dr. Sallowm has nothing to disclose.
Adam Friedant, DO	Dr. Friedant has nothing to disclose.
Hyunjin Kim, MD	No disclosure on file
Jose Luiz Pedroso, MD	No disclosure on file
Joseph Menzin, PhD	No disclosure on file
Tatiana Koudriavtseva, MD	No disclosure on file
Greg M. Thaera, MD	No disclosure on file
Masayoshi Tada, MD, PhD	No disclosure on file
Cameron Davis, MS	No disclosure on file
Kavita M. Grover, MD, FAAN	Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst.
Ikjae Lee, MD	Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lee has received personal compensation in the range of $0-$499 for serving as a Consultant for Amylyx. Dr. Lee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. The institution of Dr. Lee has received research support from CReATe consortium/American Brain Foundation. The institution of Dr. Lee has received research support from NIH.
Thomas Cochran	No disclosure on file
Anna L. Isenberg, PhD	No disclosure on file
Daniel Kaufer, MD, FAAN	No disclosure on file
Ralph H. Benedict, PhD	Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Benedict has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brystal Mier Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Benedict has received research support from Genzyme. The institution of Dr. Benedict has received research support from Biogen. The institution of Dr. Benedict has received research support from Bristol Myer Squib. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Heidi B. Schwarz, MD, FAAN	Dr. Schwarz has received personal compensation for serving as an employee of University of Rochester Medical Center. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBSCO. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepost. Dr. Schwarz has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Law Firms.
Richard S. Burns, MD	No disclosure on file
Richard J. Caselli, MD, FAAN	The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona.
Jesus Lovera, MD	Dr. Lovera has nothing to disclose.
Nobuaki Yoshikura, MD, PhD	Dr. Yoshikura has nothing to disclose.
Alessandro Biffi, MD	Dr. Biffi has received personal compensation for serving as an employee of Eli Lilly And Company. Dr. Biffi has stock in Eli Lilly And Company.
Joel Kramer, PhD	The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Rachel P. Guimaraes, PT	No disclosure on file
Supurna Ghosh, PhD	Dr. Ghosh has received personal compensation for serving as an employee of Revalesio Corporation.
Forough Ghavami, DO	No disclosure on file
Ann Scher, PhD, FAAN	No disclosure on file
Jeffery P. Hogg, MD	No disclosure on file
Timothy K. Vartanian, MD, PhD	Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Vartanian has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Vartanian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tisch MS Center. Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Amy T. Waldman, MD	Dr. Waldman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. Dr. Waldman has received publishing royalties from a publication relating to health care.
Zhixiao Wang, PhD	No disclosure on file
Elisabetta Pagani	No disclosure on file
Galeno Rojas, MD	No disclosure on file
Alaleh Raji, MD	No disclosure on file
Neeta Garg, MD	Dr. Garg has nothing to disclose.
Charles Cho	No disclosure on file
Natalya Shneyder, MD	Dr. Shneyder has nothing to disclose.
Scheherazade Le, MD	Dr. Le has nothing to disclose.
Douglas C. Smith, MD, PhD	No disclosure on file
Danilo Bernardo, MD	No disclosure on file
Ashesh Mehta	No disclosure on file
Lisa Burkholder	No disclosure on file
Syed I. Hussain, MD	Dr. Hussain has nothing to disclose.
Lauren Koffman, DO, MS	Dr. Koffman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Law Firm.
Abdulrahman Alwaki, MD	Dr. Alwaki has nothing to disclose.
Shana S. Krstevska, MD	No disclosure on file
Paul M. George, MD, PhD, MSE, FAAN	Dr. George has received personal compensation in the range of $0-$499 for serving as a Consultant for ConductiveBio. Dr. George has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law firms. The institution of Dr. George has received research support from Conductive Bio. The institution of Dr. George has received research support from NIH.
Himali R. Jayakody, MD	Dr. Jayakody has nothing to disclose.
Saima Ali, MD	No disclosure on file
Sreenivas Avula, MD	No disclosure on file
Rick Gill, MD	Dr. Gill has nothing to disclose.
Fiona E. Costello, MD	Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Accure Therapeutics. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for the Sumaira Foundation.
Henry L. Paulson, MD, PhD, FAAN	Dr. Paulson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exicure. The institution of Dr. Paulson has received research support from National Institutes of Health. Dr. Paulson has a non-compensated relationship as a Member, Nominating committee with American Neurological Association that is relevant to AAN interests or activities.
Janet Berkley	No disclosure on file
Trevor J. Kilpatrick, MBBS, PhD	Dr. Kilpatrick has received stock or an ownership interest from Mx3 diagnostics. The institution of Dr. Kilpatrick has received research support from NHMRC. The institution of Dr. Kilpatrick has received research support from NMSS. The institution of Dr. Kilpatrick has received research support from MSRA. Dr. Kilpatrick has received intellectual property interests from a discovery or technology relating to health care. Dr. Kilpatrick has received publishing royalties from a publication relating to health care.
Cormac A. O'Donovan, MD	Dr. O'Donovan has nothing to disclose.
Pedro S. Oliveira, MD	No disclosure on file
Aubrey Adams, PhD	Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Chandan B. Mehta, MD	Dr. Mehta has nothing to disclose.
Marta San Luciano, MD, FAAN	Dr. San Luciano has received research support from NIH (NINDS).
Jodie Burton, MD, FAAN	Dr. Burton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Burton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Burton has received personal compensation in the range of $0-$499 for serving as a Consultant for Horizon. The institution of Dr. Burton has received research support from Roy and Joan Allen Professorship for Sight. Dr. Burton has a non-compensated relationship as a Advisor with CADTH that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Alexion that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Horizon that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Educational Chair with EMD Serono that is relevant to AAN interests or activities.
Clinton B. Wright, MD, FAAN	An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MARSHALL DENNEHY. The institution of an immediate family member of Dr. Wright has received research support from Oncospace. Dr. Wright has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Wright has received personal compensation in the range of $500-$4,999 for serving as a surveyor with ASTRO.
Molly K. King, MD	No disclosure on file
David K. Urion, MD, FAAN	Dr. Urion has nothing to disclose.
Annapoorna Bhat, MD	Dr. Bhat has nothing to disclose.
Fernando Dangond, MD, FAAN	Dr. Dangond has received personal compensation in the range of $1,000,000+ for serving as a Head, Global Clinical Development (employee for 12 years) with EMD Serono.
Fernando F. Figueira, MD	No disclosure on file
Ellen Carl, MS	No disclosure on file
Sarah H. Ying, MD	Dr. Ying has nothing to disclose.
Prityi Rani, MD	No disclosure on file
Michael Hecker, PhD	No disclosure on file
Ramy El Khoury, MD, FAAN	No disclosure on file
Val J. Lowe, MD	Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Vikram Shakkottai, MD, PhD	The institution of Dr. Shakkottai has received research support from National Institutes of Health. Dr. Shakkottai has received publishing royalties from a publication relating to health care.
Nazli A. Janjua, MD, MBBS	Dr. Janjua has nothing to disclose.
Brij M. Ahluwalia-Singh, MD, FAAN	No disclosure on file
Justin Murphy, MD	No disclosure on file
Susanna Usai	No disclosure on file
Adam J. Simon, PhD	No disclosure on file
Xuemei Huang, MD, PhD	No disclosure on file
Umer Akbar, MD	Dr. Akbar has nothing to disclose.
Osamu Onodera, MD	Dr. Onodera has nothing to disclose.
Ghaniah Hassan-Smith	No disclosure on file
Enrique A. Serrano, MD	No disclosure on file
Kalidoss Ramadoss	No disclosure on file
Rahul H. Dave, MD, PhD	No disclosure on file
Salvatore DiMauro, MD	No disclosure on file
Joseph R. Berger, MD, FAAN	Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb/Celgene. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono/Merck. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen/J&J. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphic. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuVIR. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cellevolve. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ExcisionBio. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WebMD. The institution of Dr. Berger has received research support from Biogen. The institution of Dr. Berger has received research support from Genentech/Roche.
Nathalie Guy Renouil, MD	No disclosure on file
Michael J. Doherty, MD, FAAN	No disclosure on file
Edgardo Cristiano, MD	Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Yuichi Hayashi	Yuichi Hayashi has nothing to disclose.
Ruggero Capra, MD	Dr. Capra has nothing to disclose.
Xiaojun You, PhD	No disclosure on file
Norman Latov, MD, PhD	Dr. Latov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Polyneuron. Dr. Latov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Therapath LLC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Mcaloon & Freeman, PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conway Homer PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sylvia Chin-Kaplan, LLC. The institution of Dr. Latov has received research support from Takeda. Dr. Latov has received publishing royalties from a publication relating to health care.
Milena Pavlova, MD	Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pear Therapeutics. Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Oakstone. The institution of Dr. Pavlova has received research support from Jazz. The institution of Dr. Pavlova has received research support from Vanda. The institution of Dr. Pavlova has received research support from Biomobie. Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving as a Didactic article with Neurodiem.
Laila Gharzai	No disclosure on file
Daniel Pelletier, MD	Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Daniel Friedman, MD	The institution of Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Study Consortium (non-profit). Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Meili Technology. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Friedman has stock in Neuroview Technology. The institution of Dr. Friedman has received research support from NIH. The institution of Dr. Friedman has received research support from CDC. The institution of Dr. Friedman has received research support from Epitel. The institution of Dr. Friedman has received research support from Neuropace. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received publishing royalties from a publication relating to health care. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with SK Life Sciences. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with AAN. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Travel Reimbursement with Epilepsy Foundation of America.
Anibal Lugo, MD	No disclosure on file
Rachel Godfred	No disclosure on file
Leighton Hinkley, PhD	Dr. Hinkley has nothing to disclose.
Gaetan Garraux, MD	No disclosure on file
Govind Bhagavatheeshwaran	Mr. Bhagavatheeshwaran has received research support from National Institutes of Health.
Anelyssa D'Abreu, MD, PhD, MPH	The institution of Dr. D'Abreu has received research support from Alzheimer's and Related Diseases Research Award Fund (Virginia Center on Aging in the College of Health Professions). The institution of Dr. D'Abreu has received research support from U.S. NIH Institute on Aging. The institution of Dr. D'Abreu has received research support from Biogen. The institution of Dr. D'Abreu has received research support from American College Of Radiology. The institution of Dr. D'Abreu has received research support from COGNITION THERAPEUTICS, INC.. Dr. D'Abreu has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with Pri_med.
Jonathan Rosand, MD	Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rosand has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for National Football League. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Robert T. Wechsler, MD, PhD, FAAN	The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Raport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to AAN interests or activities.
Haitham Dababneh, MD	No disclosure on file
Geert G. Brekelmans, MD	No disclosure on file
Scott R. Haines, MD	No disclosure on file
Anya Turetsky, MD	No disclosure on file
Ignacio Demey, MD, PhD	Ignacio Demey, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Laboratorio Bagó.
Raya Massoud, MD	No disclosure on file
Dong-Hui Chen, MD, PhD	No disclosure on file
Michelle Cameron, MD	Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Bennett L. Lavenstein, MD, FAAN	No disclosure on file
Navid Seraji-Bozorgzad, MD	No disclosure on file
Matthew Imperioli, MD	Dr. Imperioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Imperioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx Pharmaceuticals . Dr. Imperioli has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law offices of Scott Doody.
Jennifer K. Lynch, MD	No disclosure on file
Mohammad H. El-Ghanem, MD	Dr. El-Ghanem has nothing to disclose.
Ismael Calandri, MD	Dr. Calandri has nothing to disclose.
Idanis Berrios Morales, MD	Dr. Berrios Morales has nothing to disclose.
Charles H. Adler, MD, PhD, FAAN	Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Osama O. Zaidat, MD, FAAN	Dr. Zaidat has nothing to disclose.
Ayaz M. Khawaja, MD	Dr. Khawaja has nothing to disclose.
Sha Mi, PhD	No disclosure on file
Zoltan Mari, MD, FAAN	Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ACADIA. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CNS Ratings. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Global Kinetics Corporation. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US World Meds. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parkinson Study Group. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GB Sciences. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for nQ Medical, Inc.. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ACADIA. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for US World Meds. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Moore and Moore PLLC. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Francis Law Firm PLLC. Dr. Mari has received stock or an ownership interest from NeuroReserve. Dr. Mari has received stock or an ownership interest from Sensory Cloud. Dr. Mari has received stock or an ownership interest from nQ Medical Inc. The institution of Dr. Mari has received research support from Cerevel. The institution of Dr. Mari has received research support from AbbVie. The institution of Dr. Mari has received research support from NIH. The institution of Dr. Mari has received research support from Parkinson's Foundation. The institution of Dr. Mari has received research support from Michael J Fox Foundation. The institution of Dr. Mari has received research support from LBDA. The institution of Dr. Mari has received research support from Eli Lilly.
J. Americo M. Fernandes, Jr., MD, FAAN	Dr. Fernandes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Columbia University. The institution of Dr. Fernandes has received research support from MGH philanthropy (Clene, Seelos, UCB, Biohaven, Prilenia, Denali Therapeutics, Calico Life Sciences. The institution of Dr. Fernandes has received research support from Columbia University. The institution of Dr. Fernandes has received research support from PTC Therapeutics. The institution of Dr. Fernandes has received research support from Clene.
Doris J. Doudet, PhD	No disclosure on file
Ryan D. Walsh, MD	No disclosure on file
Mark B. Bromberg, MD, PhD, FAAN	Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics. Dr. Bromberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Bromberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT Pharma. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received publishing royalties from a publication relating to health care. Dr. Bromberg has received personal compensation in the range of $5,000-$9,999 for serving as a Medical reviewer with Department of Justice, Vaccination Compensation Board.
Pedro Braga-Neto, MD, PhD	No disclosure on file
Andrew A. Wolff, MD	No disclosure on file
Hsueh-Sheng Chiang, MD, PhD	The institution of Dr. Chiang has received research support from NIH/NIDCD. The institution of Dr. Chiang has received research support from Texas Alzheimer's Research and Care Consortium.
Barbara Teter, PhD MPH	No disclosure on file
Brooke Hayward, SM, MBA	Brooke Hayward, SM, MBA has received personal compensation for serving as an employee of EMD Serono, Inc., Rockland, MA USA, an affiliate of Merck KGaA, Darmstadt, Germany.
Rohini Bhole, MD, MS, FAAN	Dr. Bhole has nothing to disclose.
Ramandeep Sahni, MD	Dr. Sahni has nothing to disclose.
Omotola A. Hope, MD	Dr. Hope has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Gustavo Figueira, MD	No disclosure on file
Christopher Gomez, MD, PhD	Dr. Gomez has nothing to disclose.
Amiram Katz, MD	No disclosure on file
Jeffrey Waugh, MD, PhD, FAAN	Dr. Waugh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Two independent law firms. The institution of Dr. Waugh has received research support from AAN.
Sheng-Han Kuo, MD	Dr. Kuo has nothing to disclose.
Noel Carlson, PhD	The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
David S. Tabby, DO, FAAN	No disclosure on file
Niraj A. Arora, MD	Dr. Arora has nothing to disclose.
James E. Siegler III, MD	Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various medicolegal cases. The institution of Dr. Siegler has received research support from Viz.ai.
Elijah Mak	No disclosure on file
Sandeep Vaishnavi, MD, PhD	No disclosure on file
Lutz Harms	No disclosure on file
Steve Chung, MD, FAAN	The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Karla P. Figueroa	Ms. Figueroa has nothing to disclose.
Karen C. Albright, DO, MPH	Dr. Albright has nothing to disclose.
Mira Kapisyzi, DO	No disclosure on file
Gregory A. Elder, MD	No disclosure on file
Giridhar P. Kalamangalam, MD, PhD	Dr. Kalamangalam has nothing to disclose.
Jorge Martin Gavidia Chucan, MD	No disclosure on file
Jana Lizrova	No disclosure on file
Dawn C. Buse, PhD	Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Sharanpal Mann, MD	No disclosure on file
Novraj Dhanjal, MD	No disclosure on file
Jonathan Howard, MD	Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCE Conferences. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has a non-compensated relationship as a Test writer with ABPN that is relevant to AAN interests or activities.
Kristina M. Fanning, PhD	The institution of Kristina Fanning has received research support from Abbvie. The institution of Kristina Fanning has received research support from NYC Langone Health . The institution of Kristina Fanning has received research support from Allay Lamp. The institution of Kristina Fanning has received research support from Juva Health.
Shamaehah Javed, MD	No disclosure on file
Sara A. Mayer, MD	No disclosure on file
Stefano F. Cappa, MD	Dr. Cappa has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elservier. The institution of Dr. Cappa has received research support from Italian Minsitry of Health.
Jana Preiningerova, MD	No disclosure on file
Nikolaos Evangelou, PhD	Dr. Evangelou has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis . Dr. Evangelou has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis . The institution of Dr. Evangelou has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Roche. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Evangelou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UK crown prosecution service. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis .
Nagaendran Kandiah, MD	No disclosure on file
Cynthia I. Guede, NP	No disclosure on file
Akshat Katyayan, MD	No disclosure on file
Alison May, MD	No disclosure on file
Georgia D. Montouris, MD	No disclosure on file
Shifang Liu	No disclosure on file
Karthikeyan M. Arcot, MD	No disclosure on file
John W. Day, MD, PhD	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Affinia Therapeutics. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Audentes. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Cytokinetics. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Guillaume Lamotte, MD	Dr. Lamotte has nothing to disclose.
Pezhman Roohani, MD	No disclosure on file
Melissa Murray, PhD	Dr. Murray has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avid Radiopharmaceuticals. The institution of Dr. Murray has received research support from National Institute on Aging. The institution of Dr. Murray has received research support from Alzheimer's Association. The institution of Dr. Murray has received research support from Chan Zuckerberg Initiative.
Alexander George	No disclosure on file
Gabriela Cohen, MD	No disclosure on file
Gilmar F. Prado, MD	No disclosure on file
Jens Watzlawik	No disclosure on file
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Andrea Falini	No disclosure on file
Joel Salinas, MD, MBA, MSc, FAAN	Dr. Salinas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai, Inc. Dr. Salinas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly, Inc. Dr. Salinas has stock in Isaac Health.
Jeremy Tanner, MD	The institution of Dr. Tanner has received research support from NIA.
Steven K. Feske, MD	Dr. Feske has received publishing royalties from a publication relating to health care.
James F. Meschia, MD, FAAN	The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
David F. Tang-Wai, MD, FRCPC	Dr. Tang-Wai has nothing to disclose.
Charles M. Lourenco, MD, PhD	No disclosure on file
Benn E. Smith, MD, FAAN	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSP Behring.
Radha Mahadevan, MD	No disclosure on file
Deepal P. Shah-Zamora, MD	Dr. Shah-Zamora has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Winthrop Industrie.
Drew Goldberg	No disclosure on file
Sean J. Pittock, MD	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics, Inc.. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Therapeutics. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedImmune/Viela Bio. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB, Inc. Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman/LaRoche AG. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hofman/LaRoche. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Dr. Pittock has received research support from Grifols. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Viela Bio/MedImmune/Horizon. The institution of Dr. Pittock has received research support from Alexion Pharmaceuticals. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. The institution of Dr. Pittock has received research support from NovelMed. The institution of Dr. Pittock has received research support from AstaZeneca. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Seref Demirkaya, PhD	No disclosure on file
Nitish Harid	No disclosure on file
Glenn A. Phillips, PhD	Dr. Phillips has received personal compensation for serving as an employee of argenx. Dr. Phillips has stock in argenx.
Raymond Y. Lo, MD	Dr. Lo has nothing to disclose.
Serdar Tasdemir, MD	No disclosure on file
Silvana Riggio, MD	No disclosure on file
Fatai Radji, MD	Dr. Radji has nothing to disclose.
James T. Becker, PhD	No disclosure on file
Thomas W. Smith, MD	No disclosure on file
Won-Joo Kim, MD	No disclosure on file
Dhairyawan Pokalkar, MD, FAAN	No disclosure on file
Ronald G. Haller, MD	No disclosure on file
Felicia B. Axelrod, MD	No disclosure on file
Sateesh K. Kamera, MD, DM	No disclosure on file
James Miller	No disclosure on file
Aleksandar Videnovic, MD, MSc, FAAN	Dr. Videnovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion pharmaceuticals .
Michio Hirano, MD, FAAN	Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis Therapeutics (a subsidiary of Zogenix). Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epirium Bio. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Innovation Specialist. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Platform Q Health. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Modis Therapeutics (a subsidiary of Zogenix. The institution of Dr. Hirano has received research support from Cyclerion. Dr. Hirano has received research support from Reneo Pharmaceuticals. The institution of Dr. Hirano has received research support from Astellas. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities.
Richard L. Doty, PhD, FAAN	Dr. Doty has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Sensonics International. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Doty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for State of Kansas. Dr. Doty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Johnson & Johnson. Dr. Doty has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for McMahan Law Firm. Dr. Doty has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Offices of Walkup et al.. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ostroff Injury Law PC. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sacchett & Baldino. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Nebenzahl Law Group. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ohio National Life Insurance Co. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Tatum and Atkinson LLC. Dr. Doty has stock in Sensonics International. Dr. Doty has received publishing royalties from a publication relating to health care. Dr. Doty has received publishing royalties from a publication relating to health care. Dr. Doty has received publishing royalties from a publication relating to health care.
Reyna Duron, MD	No disclosure on file
Michael Douglas, MD	No disclosure on file
Lester Y. Leung, MD	Dr. Leung has received research support from NIH.
Gil D. Rabinovici, MD, FAAN	Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Joihnson. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Rabinovici has received research support from NIH. The institution of Dr. Rabinovici has received research support from American College of Radiology. The institution of Dr. Rabinovici has received research support from Alzheimer's Association. The institution of Dr. Rabinovici has received research support from Rainwater Charitable Foundation. The institution of Dr. Rabinovici has received research support from Genentech. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Topic Chair, Course Director and teacher with AAN. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with ANA.
Bonnie M. Keung, MD	No disclosure on file
Joohi Jimenez Shahed, MD	Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bracket Global LLC. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha Omega. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. The institution of Dr. Jimenez Shahed has received research support from Michael J Fox Foundation. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with American Academy of Neurology. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on Research Grant with Florida Atlantic University. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Speaker with Tourette Association of America. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with NACCME.
Alan Lerner, MD	The institution of Dr. Lerner has received research support from Premier applied biosciences. Dr. Lerner has received publishing royalties from a publication relating to health care.
Roman Herzig, MD, PhD	No disclosure on file
Abhijeet R. Joshi	No disclosure on file
Marijean Buhse	No disclosure on file
Katherine A. Riester, MPH	No disclosure on file
Radu Tanasescu, MD, PhD	Dr. Tanasescu has received personal compensation for serving as an employee of Merck. Dr. Tanasescu has received personal compensation for serving as an employee of Novartis. Dr. Tanasescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tanasescu has received research support from UK MRC grant MR/T024402/1.
Zahinoor Ismail, MD	No disclosure on file
Daniel Vela-Duarte, MD	Dr. Vela-Duarte has nothing to disclose.
Myassar Zarif	No disclosure on file
Qian Ma, MD, PhD	No disclosure on file
Rajani Sebastian, PhD	No disclosure on file
Jeffrey J. Sevigny, MD	No disclosure on file
Heather Lau, MD	Dr. Lau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prevail Therapeutics. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ASPA Therapeutics. Dr. Lau has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Lau has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Lau has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphazyme. Dr. Lau has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biomarin. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Enzyvant. Dr. Lau has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Lau has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. The institution of Dr. Lau has received research support from Amicus. The institution of Dr. Lau has received research support from Biomarin. The institution of Dr. Lau has received research support from Genzyme/Sanofi. The institution of Dr. Lau has received research support from Shire/Takeda. The institution of Dr. Lau has received research support from Ultragenyx. The institution of Dr. Lau has received research support from Mallinckrodt. The institution of Dr. Lau has received research support from Orphazyme. The institution of Dr. Lau has received research support from Prevail Therapeutics. The institution of Dr. Lau has received research support from ASPA Therapeutics. The institution of Dr. Lau has received research support from Denail.
Aarushi Suneja, MD	Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Birgit Surböck, MD	No disclosure on file
Charu Ramchandani, MD	No disclosure on file
Francesca Rosini, MD	No disclosure on file
Ramakrishnan Ramalingam, MD, DM	No disclosure on file
Jennifer Vannest	No disclosure on file
Janet Benesh, BSMT	No disclosure on file
Lenore C. Ocava, MD	No disclosure on file
Arnaldo E. Velez, MD	No disclosure on file
Coleen Hanlon	No disclosure on file
Amanda C. Guidon, MD	An immediate family member of Dr. Guidon has received personal compensation for serving as an employee of GE Healthcare. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Guidon has received research support from MGFA. The institution of Dr. Guidon has received research support from Project Data Sphere. The institution of Dr. Guidon has received research support from MGNet. The institution of Dr. Guidon has received research support from MGNet. Dr. Guidon has received publishing royalties from a publication relating to health care.
Patricio Blaya, MD	No disclosure on file
Caroline Antoniol, MD	No disclosure on file
Nik Haliza Nik Hassan, MD	No disclosure on file
Liana Apostolova, MD, FAAN	Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Apostolova has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Association. An immediate family member of Dr. Apostolova has stock in Cassava Neurosciences. The institution of Dr. Apostolova has received research support from Roche Diagnostics. The institution of Dr. Apostolova has received research support from NIA. The institution of Dr. Apostolova has received research support from Alzheimer Association. The institution of Dr. Apostolova has received research support from AVID radiopharmaceuticals. The institution of Dr. Apostolova has received research support from Life Molecular Imaging.
Christopher Goetz, MD, FAAN	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Shu Leong Ho, MD, FAAN	No disclosure on file
Bashir S. Shihabuddin, MD	No disclosure on file
Pavel Klein, MD, FAAN	The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Christopher Schwarz	No disclosure on file
Stela Lefter, MD	No disclosure on file
Sergi Martinez-Ramirez, MD	Dr. Martinez-Ramirez has nothing to disclose.
Sarkis Morales-Vidal, MD	Dr. Morales-Vidal has nothing to disclose.
Brian D. Moseley, MD	Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has stock in UCB. Dr. Moseley has stock in Neurocrine Biosciences.
Jerry S. Wolinsky, MD, FAAN	Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Carolina De Jesus-Acosta, MD	No disclosure on file
Joon Y. Kang, MD	Dr. Kang has nothing to disclose.
Sandeep Kumar, MD	Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CRICO.
Basim M. Uthman, MD, FACIP, FAAN	No disclosure on file
Niranjan N. Singh, MD, FAAN	Dr. Singh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Barbara Bumstead, NP	No disclosure on file
Derrece K. Reid, MD	No disclosure on file
Jacquelyn Laplant	No disclosure on file
Raquel Gardner, MD	Dr. Gardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainBox. The institution of Dr. Gardner has received research support from NIH. The institution of Dr. Gardner has received research support from DoD.
Mitchel S. Berger, MD	No disclosure on file
Marcelo Rocha, MD, PhD	The institution of Dr. Rocha has received research support from NIH.
Arayamparambil Anilkumar, MD, FAAN	Dr. Anilkumar has received publishing royalties from a publication relating to health care.
Shefali Karkare, MD	Dr. Karkare has nothing to disclose.
Simona V. Proteasa, MD	Dr. Proteasa has nothing to disclose.
Stella E. Hughes, MD	Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Meeting Chair with Merck Serono. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Teacher for Nurses' meeting with Biogen. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Meeting Chair with Roche. Dr. Hughes has received personal compensation in the range of $500-$4,999 for serving as a Conference Delegate with Roche.
Alok Sachdeva, MD	No disclosure on file
Bonnie Breining	No disclosure on file
Andrea Harriott, MD	Dr. Harriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Harriott has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Harriott has received research support from Electrocore. Dr. Harriott has a non-compensated relationship as a Author agreement with Abbvie that is relevant to AAN interests or activities. Dr. Harriott has a non-compensated relationship as a Researcher/Receipt of drug with Praxis that is relevant to AAN interests or activities.
Orhan H. Akman, PhD	No disclosure on file
Elisa Canu	The institution of Elisa Canu has received research support from Italian Ministry of Health .
Pamela Federighi	No disclosure on file
Chester Mathis	No disclosure on file
Aiesha Ahmed, MD, MBA, FAAN	Dr. Ahmed has stock in Doximity.
Etienne Laverse, MBBS, BSc, MRCP	Dr. Laverse has nothing to disclose.
Sarita Said-Said, MD	Dr. Said-Said has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Gritman Medical Center.
Brendan Cohn-Sheehy, MD, PhD	No disclosure on file
Shivnaveen Bains, MD	No disclosure on file
Steven Xian, MD	No disclosure on file
Glynnis Zieman, MD, MPH, FAAN	Dr. Zieman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for National Football League.
Claudia Sobreira, MD	No disclosure on file
Erum M. Shariff, MBBS, FCPS	No disclosure on file
Matthew Harris	No disclosure on file
Srilatha Siripuram	No disclosure on file
Craig McDonald, MD	Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. McDonald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Capricor Therapeutics. Dr. McDonald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catabasis. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epirium Bio. Dr. McDonald has received personal compensation in the range of $0-$499 for serving as a Consultant for Italfarmaco. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Santhera Pharmaceuticals. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis Pharmaceuticals. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera Pharmaceuticals. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Santhera Pharmaceuticals. The institution of Dr. McDonald has received research support from Astellas. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Catabasis. The institution of Dr. McDonald has received research support from Epirium Bio. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from Pfizer. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from NIDILRR. The institution of Dr. McDonald has received research support from Department of Defense. The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Yelena G. Pyatkevich, MD	No disclosure on file
Brigitte Wildemann, MD	Dr. Wildemann has nothing to disclose.
Bruno Coutinho, MD	No disclosure on file
Emanuele Barca, MD, PhD	Dr. Barca has nothing to disclose.
Alessandro D'Ambrosio	No disclosure on file
Hans Offenbacher, MD	Dr. Offenbacher has nothing to disclose.
Thomas Seifert, MD	No disclosure on file
Fermina A. Pirmohamed, MD	No disclosure on file
Karen D. Orjuela, MD, FAAN	The institution of Dr. Orjuela has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Orjuela has received research support from Abbott. The institution of Dr. Orjuela has received research support from NIH . The institution of Dr. Orjuela has received research support from Bristol Myers Squibb Foundation.
Alberto J. Espay, MD, FAAN	Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus (formerly, USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avion Pharmaceuticals. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Jean Baptiste Chanson	No disclosure on file
Minjee Kim, MD	The institution of Dr. Kim has received research support from Genentech, Inc..
Perry K. Richardson, MD	Dr. Richardson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MedForce.
Justin T. Mhoon, MD	No disclosure on file
Maromi Nei, MD	No disclosure on file
Robert P. Rubens, MD, MBA, FAAN	Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals.
Shilpi Mittal, MD	Dr. Mittal has nothing to disclose.
Lisa Meng	No disclosure on file
Mathieu Anheim	No disclosure on file
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
William B. Young, MD, FAAN	Dr. Young has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Young has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven Pharmaceuticals Inc. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Coalition for Headache and Migraine Patients. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Miles for Migraine. The institution of Dr. Young has received research support from Amgen. The institution of Dr. Young has received research support from Cumberland. The institution of Dr. Young has received research support from Eli Lilly. The institution of Dr. Young has received research support from Novartis. The institution of Dr. Young has received research support from PCORI. The institution of Dr. Young has received research support from Satsuma. The institution of Dr. Young has received research support from Scion. The institution of Dr. Young has received research support from Teva. The institution of Dr. Young has received research support from Zosano.
Tanya J. Lehky, MD	Dr. Lehky has nothing to disclose.
Terrie Livingston, PharmD	Ms. Livingston has received personal compensation for serving as an employee of EMD Serono, Inc. Ms. Livingston has stock in EMD Serono, Inc. Ms. Livingston has stock in Biogen.
Christopher J. Boes, MD, FAAN	Dr. Boes has nothing to disclose.
Gonzalo Revuelta, DO	The institution of Dr. Revuelta has received research support from NIH.
Lyell K. Jones, MD, FAAN	Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a member of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Morris H. Scantlebury, MD	No disclosure on file
Ann Ligocki	No disclosure on file
Luigi Lavorgna	No disclosure on file
Thyagarajan Subramanian, MD, MBBS, FAAN	Dr. Subramanian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Subramanian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Subramanian has received research support from National Institutes of Health. The institution of Dr. Subramanian has received research support from American Parkinson Disease Association. The institution of Dr. Subramanian has received research support from Enterin Inc.. The institution of Dr. Subramanian has received research support from Pharma2B. The institution of Dr. Subramanian has received research support from Ann and Phillip Gladfetler III Foundation. The institution of Dr. Subramanian has received research support from Ron and Pratima Gatehouse Foundation. Dr. Subramanian has received publishing royalties from a publication relating to health care. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with National Institutes of Health.
Licia Grazzi, MD	Dr. Grazzi has received personal compensation in the range of $0-$499 for serving as a Consultant for EliLilly. Dr. Grazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan-abbvie.
Nitin Tandon	No disclosure on file
Serge Khelemsky, DO	No disclosure on file
Konrad Rejdak, PhD	Dr. Rejdak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck, Biogen, Bayer, Sanofi, Teva, Roche. Dr. Rejdak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen, Bayer, Sanofi, Teva, Roche.
Michael D. Perloff, MD, PhD	Dr. Perloff has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for several law firms/Universities.
Gianna Carla Riccitelli	No disclosure on file
Antonio Federico, MD, Prof	No disclosure on file
Allen J. Aksamit, Jr., MD, FAAN	Dr. Aksamit has nothing to disclose.
Marwan N. Sabbagh, MD, FAAN	Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Brett L. Cucchiara, MD	Dr. Cucchiara has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Elseiver. Dr. Cucchiara has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Bayer. Dr. Cucchiara has received publishing royalties from a publication relating to health care.
Nandhagopal Ramachandiran, MBBS, DM, FRCP, FAAN	No disclosure on file
Jacob S. Elkins, MD	No disclosure on file
Yael Nissan	No disclosure on file
Nolan Williams, MD	No disclosure on file
James P. Klaas, MD, FAAN	No disclosure on file
Manuela De Stefano	No disclosure on file
Maria Petracca, PhD	Dr. Petracca has nothing to disclose.
Jessica Wilcox, MD	Dr. Wilcox has nothing to disclose.
Adam Rizvi, MD	No disclosure on file
Danielle B. Pier, MD	No disclosure on file
Sahil Gupta, MD	Dr. Gupta has nothing to disclose.
Klemens Winder, MD	No disclosure on file
Suhail Al-Shammri, FRCPC, FAAN	No disclosure on file
Ayush Batra, MD	The institution of Dr. Batra has received research support from GeNeuro SA. Dr. Batra has received publishing royalties from a publication relating to health care.
Marilyn J. McKasson, MD	No disclosure on file
Vikram Shivkumar, MD, FAAN	Dr. Shivkumar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Shivkumar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion.
Qinyi Jiang	No disclosure on file
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Lydia Sharp, MD	The institution of Dr. Sharp has received research support from McNair Foundation. The institution of Dr. Sharp has received research support from ALS Association.
Jennifer Whitwell, PhD	Dr. Whitwell has nothing to disclose.
Anand Viswanathan, MD	Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals.
Kym Boycott	No disclosure on file
Olimpia Musumeci	No disclosure on file
Melissa Sorosina	No disclosure on file
Harpreet Kaur, MD	No disclosure on file
Nikolaos I. Papamitsakis, MD	No disclosure on file
Robert Kahoud	No disclosure on file
Channaiah Srikanth Mysore	No disclosure on file
Sonia N. Krish, MD	No disclosure on file
Victoria Barghout, PhD	No disclosure on file
Christian Ritter, MD	No disclosure on file
Dong Joo Yun	No disclosure on file
Yuen Kwun Wong	No disclosure on file
Chang Shek Kwan, MD	Dr. Kwan has nothing to disclose.
Ankit Pahwa	Ankit Pahwa has nothing to disclose.
Anne E. Bunner, PhD	No disclosure on file
David Miller	No disclosure on file
Jithin S. George, MD	No disclosure on file
Josiane LaJoie, MD	Dr. LaJoie has nothing to disclose.
Kasra Maasumi, MD	No disclosure on file
Ken Myers, MD, PhD	The institution of Dr. Myers has received research support from Savoy Foundation. The institution of Dr. Myers has received research support from Fonds de Recherche de Santé Québec. The institution of Dr. Myers has received research support from Liam Foundation. The institution of Dr. Myers has received research support from Grand Défi Pierre Lavoie Foundation. The institution of Dr. Myers has received research support from Epilepsy Canada. The institution of Dr. Myers has received research support from Pediatric Research Foundation.
Marcelo Mattiazzi, MD	No disclosure on file
Joseph Maytal, MD	No disclosure on file
Isabella L. Simone	No disclosure on file
Marcio L. Balthazar, MD	No disclosure on file
Silvia Messina	No disclosure on file
Aaron Schultz	No disclosure on file
Jodi W. Chardon	No disclosure on file
Adnan Subei, DO, FAAN	Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Efficient.
Jamie L. Starks, MD	Dr. Starks has nothing to disclose.
Sarah Stone, MD	No disclosure on file
Joao D. Farinhas, MD	No disclosure on file
Caroline B. Braune, MD	Dr. Braune has nothing to disclose.
Eliahu Heldman, PhD	No disclosure on file
Irwin Hollander, PhD	No disclosure on file
Ju-Young Na	No disclosure on file
Scott J. Koenig, Jr.	No disclosure on file
Juergen Haas	Juergen Haas has nothing to disclose.
Konstantin E. Balashov, MD, PhD, FAAN	Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Melissa L. Rayhill, MD, FAAN	Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Headache Cooperative of New England. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Clusterbusters. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with American Academy of Neurology.
Julie Price	No disclosure on file
Lucas D. Branco	No disclosure on file
Leopold J. Streletz, MD, FAAN	No disclosure on file
Jamie H. Campbell, MD	Dr. Campbell has nothing to disclose.
Padmaja Sudhakar, MD	Dr. Sudhakar has nothing to disclose.
Thomas Mathew, MD	Dr. Mathew has nothing to disclose.
Ludger Schols, MD	Dr. Schols has received personal compensation in the range of $500-$4,999 for serving as a Consultant for VICO Therapeutics. Dr. Schols has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Schols has received research support from Vigil.
Jose M. Chaves	No disclosure on file
Matthis Synofzik	Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphayzme Pharmaceuticals. The institution of Matthis Synofzik has received research support from EJPRD.
Paola Valsasina	No disclosure on file
Allan H. Ropper, MD, FAAN	No disclosure on file
Natarajan Visvanathan, MD, DM, FAAN	No disclosure on file
Ritesh Ramdhani, MD	Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Accorda. Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. The institution of Dr. Ramdhani has received research support from NIH. Dr. Ramdhani has received research support from Parkinson Alliance.
Eric S. Fulmer	No disclosure on file
Matteo Pardini, MD, PhD	No disclosure on file
Masoud Majed, MD	Dr. Majed has nothing to disclose.
Mario Zappia, MD	No disclosure on file
Fethi Idiman, MD	No disclosure on file
Jongyeol Kim, MD, MS	Dr. Kim has nothing to disclose.
Walter O. Arruda, MD, PhD	Dr. Arruda has nothing to disclose.
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Maria Buccafusca	No disclosure on file
Rebecca B. Williams	No disclosure on file
Andre P. Matta, MD	Dr. Matta has received personal compensation for serving as an employee of Sanofi. Dr. Matta has received stock or an ownership interest from Sanofi.
Thibault Moreau	Thibault Moreau has nothing to disclose.
Johanne Somme, PhD	No disclosure on file
Sebastian F. Ameriso, MD	Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Alireza Zandifar, MD	Dr. Zandifar has nothing to disclose.
Nestor A. Estevez, MD	No disclosure on file
Ingrid van der Mei	No disclosure on file
Javier A. Rolle, MD	No disclosure on file
Asli Koskderelioglu	No disclosure on file
Yael Reijmer	No disclosure on file
Zuzana Nedelska, MD, PhD	No disclosure on file
Gary K. Lau, MBBS	Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Dr. Lau has received research support from Croucher Foundation. The institution of Dr. Lau has received research support from Research Fund Secretariat of the Food and Health Bureau, Hong Kong. The institution of Dr. Lau has received research support from Innovation and Technology Bureau, Hong Kong. The institution of Dr. Lau has received research support from Research Grants Council, Hong Kong. Dr. Lau has received publishing royalties from a publication relating to health care.
Anindita Deb, MD, FAAN	Dr. Deb has nothing to disclose.
Raul De La Fuente-Fernandez, MD	No disclosure on file
Eduardo R. Davidovich	Dr. Davidovich has nothing to disclose.
Luis E. Bello-Espinosa, MD, FAAN	Dr. Bello-Espinosa has nothing to disclose.
Sasikanth Gorantla, MD	No disclosure on file
Salil Soman, MD	No disclosure on file
Karen Morgenshtern, MD	No disclosure on file
Richard L. Yates	No disclosure on file
Damiano Paolicelli	Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Benjamin R. Claytor, MD	Dr. Claytor has nothing to disclose.
Brian Sansoucy	No disclosure on file
Yadira Velazquez-Rodriguez, MD	No disclosure on file
Argye E. Hillis, MD, MA	Dr. Hillis has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Hillis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Hillis has received research support from NIH. Dr. Hillis has received publishing royalties from a publication relating to health care. Dr. Hillis has received personal compensation in the range of $500-$4,999 for serving as a NIDCD Council Member with NIH.
Owen A. Ross, PhD	Dr. Ross has nothing to disclose.
Gabriel Persi	Gabriel Persi has nothing to disclose.
Rodney O. Leacock, MD, FAAN	Dr. Leacock has nothing to disclose.
Virginia Laura Parisi, MD	No disclosure on file
Sharon Stoll, DO	Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for roche Genentech. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech . Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi/genzyme. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono . Dr. Stoll has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for alexion. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche/Genentech . Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for novartis. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono . Dr. Stoll has stock in BeCare Link LLC. Dr. Stoll has stock in Global Consult MS .
Naresh Mullaguri, MD	Dr. Mullaguri has nothing to disclose.
Albert E. Kim, MD	No disclosure on file
Justin Y. Kwan, MD, FAAN	Dr. Kwan has received research support from National Institutes of Health. Dr. Kwan has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with National Institutes of Health.
Morris Freedman, MD, FAAN	No disclosure on file
Horacio C. Kaufmann, MD, FAAN	Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly USA. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma UK Ltd. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaxxinity. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
Lines Vargas Collado, MD	No disclosure on file
Amna Sohail, MD	Dr. Sohail has nothing to disclose.
Jennifer R. Molano, MD, FAAN	Dr. Molano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society . Dr. Molano has received personal compensation in the range of $10,000-$49,999 for serving as a lecturer for an educational podcast series with The Teaching Company.
Tara Kimbason, MD, MPH	No disclosure on file
Jun-ichi Satoh, MD, PhD	No disclosure on file
Divpreet Kaur, MD	No disclosure on file
Alessandra Rufa, MD, PhD	No disclosure on file
Filippo Martinelli Boneschi	No disclosure on file
Facundo Manes	No disclosure on file
Ilja Bobylev	No disclosure on file
Claire Modica	An immediate family member of Claire Modica has received personal compensation for serving as an employee of Thermo Fisher Scientific. The institution of Claire Modica has received research support from Congressionally Directed Medical Research Programs. The institution of Claire Modica has received research support from Office of Naval Research.
Gosala R. Sarma, MD	No disclosure on file
Robert L. Knobler, MD, PhD	No disclosure on file
Iryna Lobanova, MD, PhD	Iryna Lobanova has nothing to disclose.
Claudio Gobbi, MD	The institution of Dr. Gobbi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Almirall, Biogen Idec, Celgene, Sanofi, Merck, Novartis, Teva Pharma, Roche.. Dr. Gobbi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Almirall, Biogen Idec, Celgene, Sanofi, Merck, Novartis, Teva Pharma, Roche..
Giuseppe Salemi, MD	No disclosure on file
E. M. Hoffman, DO, PhD	Dr. Hoffman has nothing to disclose.
Alex Nelson, MD	Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Nelson has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Lakeview Hospital. Dr. Nelson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Medical Consultants Network. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dane Street.
Gabriella Coniglio, MD	No disclosure on file
Camila C. Piccinin, MD	No disclosure on file
Felix Bermejo-Pareja, MD	No disclosure on file
Tyler Webb, MD	No disclosure on file
Mark S. George, MD	No disclosure on file
Sylvia A. Mohen, MD	No disclosure on file
Fulton Velez	No disclosure on file
Anna E. Blanken	Ms. Blanken has nothing to disclose.
M.T. Dotti, MD	No disclosure on file
Alvino Bisecco	Alvino Bisecco has nothing to disclose.
Benjamin Kay, MD	No disclosure on file
Jean-Marc Leger, MD, FAAN	No disclosure on file
Sigurlaug Sveinbjornsdottir	No disclosure on file
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Jennifer Harney	No disclosure on file
Luisa Vuolo	No disclosure on file
Noah Benson	No disclosure on file
Seok Kim	No disclosure on file
Ercan Karabacak	No disclosure on file
Jeffrey D. Bernstein	No disclosure on file
Stephan Goedee, MD	No disclosure on file
Rahul Desikan	No disclosure on file
Simona Bonavita	No disclosure on file
Jennifer R. Miller	No disclosure on file
Andrew G. Herzog, MD, MSc, FAAN	Dr. Herzog has nothing to disclose.
Anneliese Radke	No disclosure on file
Eleanor Sung	No disclosure on file
Shilpa Kolli	No disclosure on file
Ana Rodriguez Regal	Ana Rodriguez Regal has nothing to disclose.
Alyssa Brandt	No disclosure on file
Kandiah Nagaendran	No disclosure on file
Prasanna Venkatesan Eswaradass, MD	Dr. Eswaradass has nothing to disclose.
Rahul Khanna, MBBS	Dr. Khanna has nothing to disclose.
Brian Kopell	No disclosure on file
Matthieu Bereau	Matthieu Bereau has nothing to disclose.
Maria K. Storch, MD	No disclosure on file
Katherine Agoropoulou, PhD	No disclosure on file
Kaylan Burnham	No disclosure on file
Maria Gaitan, MD	No disclosure on file
Gadi Miron	No disclosure on file
Gloria Kim	No disclosure on file
Declan T. Chard	No disclosure on file
Jorge O. Norscini, MD	No disclosure on file
Lobo M. Alexander, MD, DM	No disclosure on file
Enrique L. Aradillas, MD	No disclosure on file
Maria O. Chavez, MD	Dr. Chavez has nothing to disclose.
Lee H. Schwamm, MD, FAAN	Dr. Schwamm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prime Education. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for lifeimage. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for mediasphere. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for medscape/WebMD. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Schwamm has received research support from NINDS. The institution of Dr. Schwamm has received research support from PCORI. Dr. Schwamm has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Schwamm has received publishing royalties from a publication relating to health care. Dr. Schwamm has a non-compensated relationship as a Board of directors with American heart association that is relevant to AAN interests or activities.
Mary Vo, MD	Dr. Vo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Vo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for OnPoint Legal Nursing Consulting. The institution of Dr. Vo has received research support from Takeda Pharmaceuticals.
Ayman P. Tourbah	No disclosure on file
Michael Hossack, MD	Dr. Hossack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rivanna.
Karen Berman, MD	No disclosure on file
Helen Barkan, MD, PhD	No disclosure on file
David R. Busch, PhD	No disclosure on file
Jennifer Morganroth, MD, MD/MBA	Dr. Morganroth has nothing to disclose.
Sedeek A. Elmoursi, MD	No disclosure on file
Kamalini G. Ranasinghe, MD, PhD	Dr. Ranasinghe has nothing to disclose.
Valerie Brachet, PhD	Dr. Brachet has received personal compensation for serving as an employee of Quanterix . Dr. Brachet has stock in Quanterix.
Roy E. Strowd III, MD, FAAN	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Malgorzata Jaremko, PhD	No disclosure on file
Mustafa Kendirli	No disclosure on file
Sebastian Camerlingo	No disclosure on file
Jay E. Selman, MD	No disclosure on file
Molly Zimmerman	No disclosure on file
Gabriele C. De Luca, MD, DPhil, FAAN	Dr. De Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurology Academy. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. De Luca has received research support from NIHR, BRC (Oxford). The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from UK MS Society. The institution of Dr. De Luca has received research support from Oxford-Quinnipiac Partnership. The institution of Dr. De Luca has received research support from US Department of Defense. The institution of Dr. De Luca has received research support from Wellcome ISSF (Oxford). The institution of Dr. De Luca has received research support from Bristol Myers Squibb. The institution of Dr. De Luca has received research support from University of Oxford (John Fell Fund). Dr. De Luca has a non-compensated relationship as a Editorial board member with MS Journal that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Vice-Chair of Grant Review Panel with UK MS Society that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Steering Group member with MS Academy that is relevant to AAN interests or activities.
Paul L. Durham, PhD	No disclosure on file
William Boles, MD	Dr. Boles has nothing to disclose.
Ellen Campbell, MD MB BCh BAO MRCP	No disclosure on file
Dara M. West, MD	No disclosure on file
Alice J. Schabas, MD	No disclosure on file
Claudio M. DeGusmao, MD	Dr. DeGusmao has nothing to disclose.
Frank Andrasik	No disclosure on file
Michel G. Clanet, Prof	No disclosure on file
Michelle L. Mellion, MD	Dr. Mellion has received personal compensation for serving as an employee of PepGen. Dr. Mellion has stock in PepGen.
Krai Chatamra, PhD	No disclosure on file
Richard Wise	No disclosure on file
Christopher Scherfler, MD	No disclosure on file
Mei-Sheng Duh, MPH, ScD	No disclosure on file
Petra Nytrova	No disclosure on file
Wendy Chen, MD	Dr. Chen has nothing to disclose.
Eric J. Pappert, MD	No disclosure on file
Demetrius M. Maraganore, MD, FAAN	The institution of Dr. Maraganore has received research support from Agency for Healthcare Research and Quality. The institution of Dr. Maraganore has received research support from Florida Department of Health.
Carlos Silvado, MD	No disclosure on file
Alfred W. Sandrock, MD, PhD	No disclosure on file
Serge G. Gauthier, MD	Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TauRx . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Canada . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai . Dr. Gauthier has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ENIGMA USA. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AmyriAD. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medesis. Dr. Gauthier has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karuna. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka . Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Canada. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sharon Francis Foundation . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JPAD. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lundbeck Foundation . Dr. Gauthier has received publishing royalties from a publication relating to health care.
Mark Edwards, MBBS	Dr. Edwards has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Edwards has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Edwards has stock in Brain and Mind Ltd. The institution of Dr. Edwards has received research support from NIHR. Dr. Edwards has received publishing royalties from a publication relating to health care.
Joao O. Siffert, MD	No disclosure on file
Luisa Maria Villar Guimerans, MD	No disclosure on file
Josep Gamez, MD, PhD	The institution of Dr. Gamez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. The institution of Dr. Gamez has received research support from Government of Spain (FIS FEDER).
Walter Royal III, MD	No disclosure on file
Donna L. Masterman, MD	No disclosure on file
Joerg Windsheimer, MD	No disclosure on file
Pascal Maisonobe	No disclosure on file
Gilbert R. Gonzales, MD	No disclosure on file
Kathryn A. Giles, MD	No disclosure on file
Nicholas D. Lawn, FRACP, MBCHB	Dr. Lawn has nothing to disclose.
Sanjay Gandhi, MD	Dr. Gandhi has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Richard A. Macdonell, MD, FAAN	Dr. Macdonell has nothing to disclose.
Jimmy Schiemann	No disclosure on file
Cinzia Cordioli, MD	Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Deborah Reed, MD	No disclosure on file
Hideki Garren, MD, PhD	No disclosure on file
Stefan Braune	Stefan Braune has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTransData. Stefan Braune has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Stefan Braune has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for NeuroTransData.
Claire E. Carrazco, DO	No disclosure on file
Guido Sabatella	Guido Sabatella has received personal compensation for serving as an employee of Alexion.
James G. Yarger, CEO	No disclosure on file
Robert Lenz, MD	No disclosure on file
Marilyn R. Semenchuk, PharmD, MSc	No disclosure on file
Nicholas Boulis	Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sio Gene Therapy. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BlueRock. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CODA Bio. Nicholas Boulis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Gibbs Attorneys. Nicholas Boulis has received stock or an ownership interest from Curative. Nicholas Boulis has received stock or an ownership interest from Remotor. The institution of Nicholas Boulis has received research support from NIH. Nicholas Boulis has received intellectual property interests from a discovery or technology relating to health care. Nicholas Boulis has received intellectual property interests from a discovery or technology relating to health care. Nicholas Boulis has received intellectual property interests from a discovery or technology relating to health care. Nicholas Boulis has received intellectual property interests from a discovery or technology relating to health care. Nicholas Boulis has received publishing royalties from a publication relating to health care.
Lecio Figueira Pinto, MD	No disclosure on file
Michel Gillard, PhD	No disclosure on file
Lindsay R. Chura, PhD	No disclosure on file
Andreas Lysandropoulos	Andreas Lysandropoulos has nothing to disclose.
Feride H. Frech, PhD	Dr. Frech has received personal compensation for serving as an employee of Eisai Inc.
Roshan L. Koul, MD, DM, FRCPCH	No disclosure on file
Matthew Farrer, PhD	No disclosure on file
Vivay Peter Misra, MD	No disclosure on file
Savary Om	No disclosure on file
Gaelle Klingelschmitt	No disclosure on file
Dimitri M. Kullmann	No disclosure on file
Edward Firouztale, DO, DSc, FAAN	No disclosure on file
Erica Selheimer, MD	No disclosure on file
Paulo P. Fontoura, MD, PhD, FAAN	Dr. Fontoura has received personal compensation for serving as an employee of F. Hoffmann La Roche. Dr. Fontoura has stock in Roche Pharmaceuticals.
Anyzeila Diaz, PharmD	No disclosure on file
Paul Lingor, MD	No disclosure on file
Martin Nevrly, MD	No disclosure on file
Simon Borghs	No disclosure on file
Wolfgang Heide, MD, FEAN	No disclosure on file
Francisco Zagmutt	No disclosure on file
Nicholas J. Everage	No disclosure on file
Nadia B. Ben Ali, PhD	No disclosure on file
Augusto Grinspan, MD	No disclosure on file
Sonia Khan	No disclosure on file
Jaclyn B. Caccese, PhD	No disclosure on file
Eric Swayze, PhD	No disclosure on file
Evelyn Olson	No disclosure on file
Monica Margoni	Monica Margoni has received research support from MAGNIMS. Monica Margoni has received research support from Merck-Serono. Monica Margoni has received research support from Sanofi-Genzyme.
Xiaolan Ye, PhD	No disclosure on file
Matthew Klein	Matthew Klein has received personal compensation for serving as an employee of PTC Therapeutics. Matthew Klein has stock in PTC Therapeutics. Matthew Klein has received publishing royalties from a publication relating to health care.
Frederic Sedel	No disclosure on file
John Ko, PharmD, MS	Dr. Ko has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Ko has received personal compensation for serving as an employee of Novartis. Dr. Ko has received stock or an ownership interest from Alnylam Pharmaceuticals. Dr. Ko has received stock or an ownership interest from Novartis.
Niamh Murphy	No disclosure on file
Dimitri Guala	No disclosure on file
Eugene M. Gan	No disclosure on file
Steven H. Nye, PhD	No disclosure on file
Ying Wu	No disclosure on file
Bernd C. Kieseier, MD	Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
Yan Ling	No disclosure on file
Claudia Prada	No disclosure on file
Ying Liu	No disclosure on file
Peter McCroskery	No disclosure on file
Nicola De Rossi	Nicola De Rossi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Nicola De Rossi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Nicola De Rossi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Audra Boscoe	No disclosure on file
Julie Moberg	No disclosure on file
RJ Wirth, PhD	RJ Wirth has received personal compensation for serving as an employee of Vector Psychometric Group, LLC.